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ABSTRACT  
 
Opiate, dopamine and GABA addictions are complex diseases with strong genetic 
components. These three substance disorders represent significant costs to the global 
judicial and healthcare systems. The treatment of addiction is further confounded by the 
co-occurrence of other pathologies that complicate treatment regimes. For example, 
addiction and mental health are well-characterized co-morbidities.  Mental health 
conditions such as depression, bipolar disorder and schizophrenia have clear genetic 
synergies between the prevalence of one mental health condition and addiction.  This 
dissertation focuses on the characterization of addiction hotspots in the genome, their 
interplay with mental health genetics and then examines how infectious disease burden 
is correlated to the rise of immune and addiction variants. 
 
Molecular genetics, metabolism analyses, epigenetic and association studies have 
contributed to current understandings of the genetic components of addiction disorder 
phenotypes. The resulting literature curated gene sets can be used to identify the 
modules and pathways mediating shared addiction, mental health and immune 
disorders. Studying addiction, mental health and immune genes in a geographically 
diverse sample of human populations is critical to understanding the role that 
evolutionary factors play in the rise and maintenance of variation potentially underlying 
addiction phenotypes. These human population comparisons are possible due to the 
recent expansion of human polymorphism databases, such as the HapMap Project, the 
Human Genome Diversity Panel and the 1000 genomes datasets. Careful comparisons 
of allele frequencies in human populations can point to those polymorphisms for which 
14 
 
both functional and evolutionary histories converge to either promote or inhibit addiction, 
mental health, and immune susceptibility. 
 
We can project curated addiction genes onto gene ontology categories and cellular 
pathways to draw a bioinformatics portrayal of addiction and its interplay with mental 
health and immunity. These addiction genes lists as well as schizophrenia, depression, 
and bipolar disorder gene sets can be further projected onto the genome to portray the 
overlap between addiction and mental health disorders. This can also serve as a tool to 
discover additional genes that play a candidate role in mental illness and addiction. 
Functionally annotating these regions using existing databases such as the Kyoto 
Encyclopedia of Genes and Genomes allows for robust characterization of the roles that 
genes and genomic regions play in modulating addiction phenotypes. This approach 
enables the identification of candidate genes sitting adjacent to known addiction hotspot 
genes and the subsequent identification of the candidate polymorphisms in a diverse 
array of human populations.  Finally the addition of new databases of genome wide 
association studies can inform candidate polymorphisms for addiction, mental health 
and immune response to infectious disease. 
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Introduction 
A central tenet of evolutionary analysis is the idea that natural selection influences allele 
frequencies in populations affected by an environmental selective agent.  The 
mechanism of natural selection is governed by four principles: the occurrence of trait or 
phenotypic variation in populations, the fact that trait variation is heritable through 
Mendelian genetic mechanisms, that this genetic variation  leads to differential fitness 
and survivability, there is competition among individuals in the population with those of 
highest fitness contributing the most to reproduction (2, 3). These principles were further 
supported by the evolutionary modern synthesis in the 1930s, which merged Darwinian 
natural selection with Mendelian mechanisms of genetic inheritance. With both the 
mechanisms and the mode of inheritance clarified, many turned their attention to the 
selective agents that could create differences in allele frequencies in human 
populations.  In 1949, Haldane predicted that infectious disease what a primary driver of 
human immune variation (4). No selective agents have been characterized as more 
important in human history in shaping allele frequency differences in and between 
human populations than infectious disease (2, 5-17). This view has been largely 
adopted to become prevalent in human evolutionary biology, human genetics and has 
served as the foundational underpinnings of the movement towards personalized 
genetics. 
 
This view has been borne out by numerous studies of human immunity related 
allozymes conducted on infectious diseases such as the host-pathogen-vector triangle 
that characterizes Malaria (P. falciparum in Africa and P. vivax in Asia) (18).  Malaria is 
a widely prevalent disease currently affecting as many as 2.7 billion people, and killing 
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approximately 1 million people a year, most of whom are young and living in Africa (19-
22). As such, malarial disease is one of the most significantly impactful infectious 
diseases studied in recorded human history. It is known to have shaped human history 
and survival in equatorial regions, and has been documented to have had extended 
geographical ranges. Recent literature has identified that Plasmodium falciparum has 
been thought to have spread approximately 13,000 years ago in concordance with 
Neolithic human expansion (23). This corresponds to estimates of dating for malarial 
disease in human populations (24, 25).  The severity of infectious diseases such as 
malaria infection in current human populations and the supposition that malaria has 
exerted similar types of selection pressures throughout its shared history with Homo 
sapiens makes it and other infectious disease strong candidates for disease- driven 
selection in humans (19, 20, 26, 27).  
 
Gene studies associated with infectious diseases have fallen in three classes: 
erythrocyte, cell receptor, and immune genes.  We previously lacked the necessary 
insights into the full scope of human loci impacted by interactions with infectious 
diseases in human hosts. This predicament stemmed largely from technological 
limitations to large scale molecular locus characterization. This has been largely 
rectified with pyrosequencing techniques and high throughput sequencing to discern 
both genomic and polymorphic regions of interest (28-31) . Recent advances in 
sequencing and functional genomic typing of genic regions has greatly broadened the 
extent and depth of our understanding of molecular targets of human evolution (29).  
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Infectious disease continues to be viewed as the major cause of the differential survival 
that is known to shape allele frequency differences.  We have noted that the study of 
selection in human populations rarely makes the leap to what fitness or evolutionary 
consequences that human migration (largely to the United States) via the trans-Atlantic 
slave trade and American immigration has caused. In my dissertation work, I will look 
for links between the immune driven selection on infectious disease traits and common 
chronic diseases for which American are co-susceptible- addiction disorders and mental 
health conditions (32, 33).  These two broad disorders are often co-morbidities with 
immune deterioration in chronically mental ill (34, 35) or with chronic substance abusers 
(36-39). We chose these two broad classes of disorders based on their co-morbidity in 
American populations (32, 36, 40, 41), and the shared clinical manifestations among 
chronic dopamine, opiate and GABA addiction sufferers (32, 39, 42). 
 
Given the confluence of these two chronic conditions in human populations and the 
observation that they both share strong immunity overlaps in the clinical literature, it 
would be particularly interesting to characterize how much genetic overlap exists in 
these seemingly etiologically different disorders. We choose to study the most common 
illicit addictive substances- cocaine, methamphetamine, heroin, morphine, alcohol, and 
GHB. These six addictive substances fall into three drug classes: dopamine, opiate and 
GABA receptor based addictions they were also chosen based on their clinical 
similarities in chronic abusers.  
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Currently we have identified the genetic inputs to our analyses (immune, addiction and 
mental health genes), and the evolutionary framework within which we are interested in 
contextualizing our work. When we considered how to best exploit the publicly available 
datasets, we considered those curated by the three datasets:  Online Mendelian 
Inheritance Map (OMIM), the National Center for Bioinformatics Information Gene 
(NCBI Gene), and The Kyoto Encyclopedia of Genes and Genomes (KEGG). Each of 
these datasets contains genes identified through experimental or clinical studies to be 
associated with a specified addiction, mental health or immunity disorder.   OMIM is a 
compendium of human genes and genetic phenotypes (43-45). OMIM is curated by 
Johns Hopkins University and housed at both omim.org and at NCBI’s portal. The NCBI 
GENE dataset is curated database of genes derived from fully sequenced genomes 
housed on the NCBI web portal. NCBI Gene integrates information from OMIM, and 
creates links to OMIM, at both the gene and the phenotype levels (Gene Help). KEGG 
is an interactive database that seeks to unify molecular processes, genetics and 
chemical interactions together to form a cohesive picture of how genes products interact 
with each other and their environment (46-50). KEGG can be queried to address both 
how genes of interest interact in genome and to identify which genes act in particular 
phenotypes or disorders(47, 48).  KEGG is curated by the Kanehisa Labs jointly at the 
Kyoto University and the University of Tokyo. Each of these datasets provides some 
benefits for our analyses input files.  
 
In order to assess which dataset is most appropriate the mine for the initial list of genes 
that will serve as the input upon which we will perform computational analyses, we 
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surveyed the  opiate, dopamine, and GABA addiction in all three datasets and 
determined which one had the most robust gene list with which to begin analyses. In 
Figure 1, we demonstrate that OMIM contained 42 gene results, NCBI GENE contained 
587 gene results and KEGG contained 139 gene results. Additionally NCBI GENE 
contained all but 50 genes of the OMIM and KEGG gene sets.  Based on these 
analyses and the previously stated linkages between OMIM and NCBI GENE, we have 
determined that NCBI GENE is the most robust dataset with respect to diversity of the 
genes represented and inclusion of the genes captured by other publicly available gene 
datasets.  
 
 
After determining that we could use the NCBI dataset as a strong input set, we wanted 
to outline the workflow that we intend to employ during the execution of this dissertation.  
 
Figure 1: Intersection of the Addiction gene sets identified in KEGG, NCBI OMIM and NCBI 
Gene. Genes involved in dopamine, opiate and GABA addiction were surveyed in each data 
set including: the Kyoto Encyclopedia of Genes and Genomes (N=139 genes), The Online 
Mendelian Inheritance Map (N= 42 genes) and the National Center for Bioinformatics 
Information Gene (N=587 genes).  
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In Figure 2 we outline the work flowchart for this dissertation. This dissertation seeks to 
identify significant human SNPs of interest in chronic disorders for which we have 
limited understanding of the biomarkers for disease. I propose to use gene sets 
identified through the NCBI Gene lists which are by and large the most complete data 
sets of their kind.  These gene lists for selected types of addiction, mental health and 
immune disorders will be mined for each disease constellation of interest.  
We will use NCBI gene sets as inputs covering addiction (specific aim 1), addiction with 
mental health (specific aim 2), and addiction with immunity (specific aim 3).  We will 
then conduct computational analyses to determine whether genes involved in different 
disorders shared genomic locality. If this was the case then we could use these 
locations to characterize the human variation present and make inference about the 
relationship between this variation and geographical/environmental variation. 
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Opioid, Dopamine and GABA Addiction  
Addiction disorders represent a major economic and health cost to human populations 
(2). Addiction is loosely defined as a chronic relapsing spectrum disorder characterized 
by loss of control over substance taking (3-5). It is a behavior-based phenomenon 
 
Figure 2: Flowchart of dissertation work inputs and outputs. NCBI Gene 
searches will be used to conduct computational analyses, identify complex disease 
hotspots, and then examining the variation found in human populations derived from 
the HapMap SNP dataset, the Human Genome Diversity Panel, and the 1000 
Genomes SNP dataset. 
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representing a diverse array of psychological, biological, and genetic attributes and 
environmental and cultural factors (6-8).  While the genetic components of addiction is 
not fully characterized, clear evidence in the form of single gene association studies, 
and genome wide association studies suggest a large role for heritable variation in 
shaping the phenotypes observed in dopamine, opiate and GABA based addictions. 
These studies provide a robust substrate on which to consider how addiction genes 
might be working together to create the functional characteristics of addiction seen in 
clinical populations.  
 
Traditional approaches to studying multiple gene interactions have focused on 
identifying how genes form gene networks and thereby contribute to functional 
pathways. These two approaches have provided significant insights into the functional 
role that genes play in relationship their network neighbor genes. These types of studies 
have led to the curation of a large list of genetic contributors to complex disease 
phenotypes such as substance addictions, mental health conditions, and infectious 
diseases. Currently, substance addiction contains a large set of genes identified as 
participating to the generation of its phenotypes. Researchers of addiction have also 
mapped many of these addiction related genes onto gene ontology pathways to further 
elucidate their role in addiction. This wealth of genetic targets for addiction has not lead 
to an understanding of which genes or polymorphic variants are the most important in 
identifying substance addiction susceptibility or addiction disorder progression. Faced 
with a wealth of genetic targets for analysis, we try to identify those genes that appear 
to have genetic relationships beyond their roles as functional agents in pathways.  
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Addiction Intersections with Schizophrenia, Depression and Bipolar Disorder 
As with addiction, neurological disorders such as depression, bipolar disorder, and 
schizophrenia represent a significant strain on health and judicial entities. Both addiction 
and mental health disorder classes have long been identified as co-morbid conditions 
(9). While we can make clear inferences about the role that genes play in Mendelian 
genetic disorders, characterizing the genetic underpinnings of complex disease has 
been significantly more challenging. The intersection of two complex diseases such as 
addiction and mental provides an additional level of genetic complexity. Both Substance 
addiction and mental health are behavior-based phenomenon representing a diverse 
array of psychological, biological, and genetic attributes and environmental and cultural 
factors (6-8, 10, 11).   
 
Schizophrenia is a mental illness that affects 1% of the global human population (12). It 
is identified as a disorder that disrupts brain neural networks and is characterized by 
hallucinations, delusions, lack of willpower, and cognitive deficits (13). Genealogy 
studies have shown that there is a strong genetic component to schizophrenia with 
genetic components accounting for as much as 80% of the risk variance (14). Linkage 
studies and candidate gene approaches have identified over 1000 candidate genes 
associated with schizophrenia.  
 
Bipolar disorder is complex and severe mental disorder found in approximately 2.6 
percent of American adults (15).  It is a disorder with genetic concordance rates for 
bipolar disorder in twin studies has been estimated to be between 60% and 80% (16).  
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Along with schizophrenia, there are a number of clinical symptoms overlap with bipolar 
disorder that may lead to these two disorders being consolidated into one mental health 
classification (17) . Finally, depression is a mood disorder experienced by 1 in 6 
Americans (18). These three mental health conditions taken together represent one of 
the top 10 diseases in terms of life years lost (19). Examining the intersection of genes 
involved in these complex disorders allows us to potentially determine the role that each 
play and how they contribute to trait sharing. 
 
Infectious disease and Immunity 
Human immunological interactions with their environment are the substrate for natural 
selection. One approach to studying natural selection in humans has been to examine 
single genes in a population to directly assess selection caused by some environmental 
effect (i.e. HBB and malaria, SLC24A5 and UV exposure)(20, 21). An analysis 
conducted on global populations has demonstrated success in identifying variation in 
allele frequencies between populations taking into account diet, subsistence strategy 
and ecoregions (22, 23).  
 
This approach allows for finer scale patterns of molecular evolution to be observed 
within a Bayesian framework. This method also harnesses the strengths of a candidate 
gene approach by selecting metabolic pathways involved in specific traits of interest 
(24).  Hancock et al. find that signatures of selection are seen in multiple pathways in 
human populations (22, 23).  Indeed this approach can be seen as a major innovation in 
multivariate analysis for factors affecting gene frequencies in human populations. 
Applying this approach to a chronic disease like addiction will be a novel use of a 
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relatively underutilized approach. The interplay of addiction, location, and immunity 
invoking exposure to pathogens are compelling external forces that impact individual 
survival and therefor gene patterns.  
 
By examining correlations between environmental, addiction, and disease conditions 
with allele frequencies, I will be able to search for allele frequencies consistent with 
signatures of selection on multi-locus traits.  This method is useful in identifying 
adaptations (whether tolerance or resistance focused) for complex infectious diseases. 
Tropical populations provide an opportunity to examine how environmental effects affect 
complex traits because they exhibit a variety of subsistence strategies, population 
histories and exposures to infectious disease. They also live in a variety of ecological 
regions, nutritional contexts and latitudes. These various conditions make them a living 
laboratory for studies in natural selection. Until recently there was not sufficient 
sampling coverage in Asian populations to make inference about populations. The 
confluence of novel population datasets spanning the world and a new methodology 
that can exploit a candidate gene-like approach to identifying selection in human 
populations makes tropical dwelling populations a compelling system to assess natural 
selection events.  
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Specific Aim I: Identification of Addiction Hotspots 
Introduction 
Addiction disorders represent a major economic and health cost to human populations 
(51). Addiction is loosely defined as a chronic relapsing spectrum disorder characterized 
by loss of control over substance taking (52-54). It is a behavior-based phenomenon 
representing a diverse array of psychological, biological, and genetic attributes and 
environmental and cultural factors(55-57).  Additionally, individuals addicted to illicit 
substances are stigmatized, with widespread marginalization of rehabilitation and 
recovery services, perhaps facilitating return to recidivism (58-60). Current methods in 
overcoming addiction induced destructive behavior include those emphasizing not the 
treatment but complete abstinence from addictive substances (37, 61).  
 
A large number of studies including genome wide association investigations has 
uncovered potentially relevant allelic contributors to the genetic and molecular basis of 
addiction phenotypes(62-68). Genetic studies such as those conducted on alcohol 
dehydrogenase variants and the ADH family has been important for advancing our 
understanding of the genetic basis of addiction phenotypes(69, 70). Literature points to 
two main molecular areas underlying addiction phenotypes. The first is the analysis of 
disruption of normal ranges of neurological function (71-73). This has been 
characterized well both in the literature and in the canonical pathways that have been 
identified as participating in addictions, such as the alcoholism, cocaine, and 
dopaminergic abuse (74-76). The second is addressed at the level of metabolic 
function(77) such as the characterization of the ADH gene family and its function in the 
metabolism of alcohol products (78, 79). 
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Association studies are yet to provide a complete picture for elucidating the complex 
pathways and mechanisms underlying addiction phenotypes. The population subtype 
dependent mechanisms of addiction have not been fully explored  (80-82) and so are 
epigenetic factors involved in addiction (36, 40, 83, 84). A big part of the problem is that 
tissues involved in addiction, neurons and liver tissue, cannot be experimentally 
investigated in the human. Hence animal models and in vitro experiments have been 
used to quantify epigenetic changes  along with those related to transcriptome  (85-87) , 
metabolome  (88-90), and proteome (91-93) in the neuron synoptic system and in the 
liver tissue under addiction disorder conditions. These animal studies have shown that 
there is a robust set of homologous genes and pathways involved in addiction (94).  
 
Studies on the human tended to focus attention on the predominantly European and 
African American addicted cohorts with few studies examining other populations (95, 
96). Familial addiction behavior patterns have long been observed to vary within and 
between ethnic communities (55, 97) . This has limited our ability to understand how 
addiction gene variation plays out in the geographically and ethnically diverse human 
populations that are afflicted by addiction disorders. Using a diverse array of ethnic 
populations representing major human geographical regions and ancestries would be 
particularly useful in understanding the role that variation at potential addiction complex 
sites in the genome plays.  
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In this study we focus on opiate, dopamine, and GABA addiction disorders. We map 
literature curated addiction genes onto human chromosomes. Clusters these genes 
form identify hotspot locations on the genome.  Addiction hotspots contain genes 
previously not linked to addiction as well as regulatory motifs with population subtype 
dependent polymorphisms. Our bioinformatics based discovery and subsequent 
investigation of addiction hotspots reveal their roles in addiction as well as the 
dependence of addiction motifs on population subtypes. Results point out multiple 
hotspots participating in pathways of addiction.  Our findings also point to possible roles 
of SLC membrane transport proteins on population type dependence of addiction.   
 
Specific Aim: Characterize the role of genome locality on addiction disorders and 
how that variation is partitioned in human populations 
 
I hypothesize that genes involved in the characterized opiate, dopamine and GABA 
addiction disorders will form genomic regions of with functional specificity. These 
regions should exist above and beyond that small subset of genes that are shared 
between these gene lists. This hypothesis derives from the anecdotal observation that 
individuals with chronic substance addiction have shared traits that appear to be 
maintained, despite the divergent mechanisms underlying metabolism of these 
substances. I further hypothesize that addiction hotspots have ethnic and regional 
specificity. The rationale behind pursuing this approach is that genes involved in 
common addiction phenotypes should have common variants underlying them. In order 
to understand the ways in which genetic variation segregates in human populations and 
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its potential implications in personalized treatment regimens to addiction, we need to 
survey how variation at regions of the genome responsible for addiction phenotypes is 
partitioned in human populations. 
 
METHODS 
Addiction linked genes and genome hotspots 
A simple search of NCBI Gene based on strings of two words shown in Fig. 1 was used 
in order to generate a list of genes with biological relevance to addiction. We focused on 
addiction linked to dopamine (cocaine and crystal methamphetamine), opiate (heroine 
and morphine), and GABA (Alcohol and GHB). Then we mapped the resulting list of 
genes on human chromosomes and considered the clusters they form (98-100).  Then, 
we used the output BED files to visualize the cluster genes at UCSD’s Genome browser 
as a custom track using the HG-19 build of the genome.  
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Figure 3: Flowchart for identifying biologically relevant addiction genes.  The 
search terms used at NCBI Gene to populate a list of unique addiction genes are 
shown. The heat maps indicate intersection of gene sets in three classes of addiction:  
dopamine, opiate, and GABA. Addiction hotspots were defined at a genomic region 
with six or more addiction genes within a 1-1.5Mb genomic window. A Venn diagram 
shows the comparison with the 387 genes identified through an alternate addiction 
study(1). 
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Hotspots were defined as genic regions approximately 1- 1.5 Mb in length along the 
genome, which contained six or more genes identified from our combined addiction 
gene list. Each hotspot contained genes not currently associated with the addiction 
phenotypes.  We included such genes into our analysis due to high probability of 
common regulation patterns within a hotspot. Next we investigated the statistical 
significance of observing six or more genes as hotspots, given a starting number of 587 
addiction associated genes. We ran in silico computations that choose 587 genes 
randomly in 10,000 simulations and counted the number of times one saw at least the 
same number of hotspots we found with our list.  
 
Functional Annotation of Hotspot Genes 
Genes located within hotspots were considered in two ways in statistical enrichments: 
all genes in the hotspot window, and only those previously linked to addiction.  All genes 
in the hotspots were annotated using DAVID’s Bioinformatics Resources Tool software 
(101, 102) for biological process, molecular function, cell compartment and KEGG 
pathways (46, 49). Functional enrichments were quantified using Benjamini score 
analysis cutoffs of 0.01 (103). A MATLAB code was written to multi-color the nodes in 
KEGG pathways to differentiate between genes belonging to different hotspots. 
 
Genetic variation in hotspots in population subtypes 
We examined the hotspot associated polymorphisms identified in 11 HAPMAP sample 
populations with distinct geographical occupation: East Asian ancestry [Japanese-JPT, 
Chinese (collected in Beijing)-CHB, Chinese (collected in Denver)-CHD], African 
ancestry populations [Yoruba-YRI, Masaai-MKK, Luhya-LWK, and African Americans-
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ASW], European ancestry populations [Europeans of Northern and Western Ancestry-
CEU and Toscana- TSI], a South Asian ancestry population [Guajarati in Houston-GIH]; 
and an admixed American population [Mexicans in Los Angeles-MEX] (104-106)  
(Table1).  To exclude the possibility of confounding effects of population-specific 
demography and to set up an empirically derived neutral estimate of allelic variation, we 
analyzed 20 concatenated autosomal loci across the human genome identified as 
neutrally evolving (107). It was assumed that the polymorphism variation undergoing 
selection will have non-neutral allele frequency patterns. SNP frequencies were trimmed 
to exclude SNPs that were almost fixed in populations (> 0.9) or of low frequency (< 
0.15). Average SNP frequencies were calculated across the window and compared in 
all populations.  
Geographical 
Region 
Population Population 
Code 
DNA 
Samples 
(2N) 
African Yoruba in Ibadan, Nigeria  YRI 220 
Maasai in Kinyawa, Kenya MKK 205 
Luhya in Webuye, Kenya LWK 122 
African Ancestry in SW USA  ASW 98 
East Asian Han Chinese in Beijing, China CHB 162 
Japanese in Tokyo, Japan  JPT 131 
Chinese in Denver, CO, USA CHD 129 
Western 
European  Northwestern European Ancestry in UT, USA CEU 180 
Toscana in Italia TSI 114 
    
South Asian Gujarati Indians in Houston, TX, USA  GIH 117 
American Mexican Ancestry in LA, CA, USA  MEX 104 
 
Table 1: Population subtypes considered at Addiction Hotspots. The eleven 
HapMap populations grouped into geographical regions. Populations are described by 
ethnic identity and by their sample collection location.  
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To test for polymorphism deviations from neutral demographic patterns, we used the 
neutral autosomal regions and then used these combined autosomal region to give us a 
sense of the average allele frequencies per population in the absence of selective 
forces.  The Kolmogorov-Smirnov test (108) was performed to test for significance 
between the frequencies of neutral regions and the seven addiction hotspots. 
Comparisons were also made between sample ethnic populations for each hotspot. 
Populations were clustered by regional ethnic origin: Africans (Luhya (LWK), Masaai 
(MKK), Yoruba (YRI), and African Americans (ASW)); Asians (Chinese-Beijing (CHB), 
Chinese-Denver (CHD), and Japanese (JPT)); and Europeans (Western Europeans 
(CEU) and the Toscana (TSI)).   
 
Populations were compared African to European, African to Asian and European to 
Asian in order to identify the pairwise significantly different polymorphisms among all 
comparisons using a chi squared test which tested the divergence of the frequency 
ratios from 1. The significant polymorphisms were then sorted by their genomic location, 
as coding, intronic or intergenic polymorphisms. 
Additionally, we examined common polymorphisms with significantly different allele 
frequencies using GWAS3D, a web-based software that identifies regulatory elements, 
long range linkage and cross chromosome interactions (109).  We also identified 17 
significant polymorphisms from six addiction studies curated by GWAS Central(110). 
These polymorphisms were then identified in the 11 sample populations of the HapMap 
dataset. 
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RESULTS 
Molecular functions and biological processes of addiction genes 
A list of biologically relevant genes for addiction was gathered from literature curated 
sources. Figure 1 shows the flowchart employed to identify biologically relevant 
addiction genes and the resulting number of genes in each addiction gene set. Three 
classes of addiction genes were obtained using the NCBI gene search: dopamine 
addiction genes (N=108), opiate addiction, (N=246) and GABA addiction genes (N= 
433). The search word chains consisted of ‘metabolism’ (N=398 genes) or ‘addiction’ 
(N=461) followed by the names of three addictive substances: dopamine, opiates and 
GABA receptor. The respective heat maps in Figure 3 illustrate the intersections within 
the search terms for both metabolism and addiction gene lists. Additionally, we 
compared our gene list to the one reported by Li, Mao and Wei (1),  containing 387 
genes involved in four addiction disorders.  This comparison is shown using a Venn 
diagram with the bulk of genes (N=311) not identified in our analyses belonging to 
nicotine addiction, an addiction disorder we do not address here.  The rest was added 
to our gene list. A set of addiction genes (N=587), compiled from the union of all search 
terms, was thus determined.   
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Figure 4: Gene ontology molecular function annotations for dopamine, 
GABA and opiate addictions. The top 75 significant functional annotations were 
obtained (Benjamini > 0.01) for gene ontology molecular function for each 
addiction gene class. The vertical axis of each graph shows the –log10 (p) while 
the horizontal axis indicates the functional annotations. The gene lists are color 
coded for opiates (green), GABA (red), and dopamine (blue).  
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Functional annotation was undertaken for the list of addiction genes, the GABA, opiate, 
and dopamine addiction classes, and their pairwise intersections. Figure 4 shows the 
top 75 statistically enriched molecular functions for the dopamine, opiate, and GABA 
gene sets. Functional annotation shows a wide range of biological processes dominated 
by cell-cell signaling.  Dopamine and opiate addiction gene lists shared many more 
molecular functions with each other than they did with the GABA addiction gene set. 
The genes common to three types of addiction under consideration included those with 
ligand-gated ion channel activity, neurotransmitter binding, and amine binding activities. 
The biological processes enriched included response to organic substances, synaptic 
transmission processes, and response to endogenous stimulus process (not shown).  
 
Figure 5 shows the overlap in the gene sets associated with the opiate, dopamine, and 
GABA classes of addiction. The figure provides the gene symbols for each intersection 
subset. Substantial sets of genes were shared amongst all addiction types (N=51 
genes). This subset included CREB genes, leucine zipper family of DNA binding 
proteins; GRIN genes, which code for glutamate-gated ion channels; and SLC genes, 
which are sodium: neurotransmitter transporters.  
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Genes sitting in the intersection of opiates and GABA addiction included genes of the 
GABR family, mediating the fastest inhibitory synaptic transmission in the central 
nervous system. Also present at this intersection subset were genes from the 
GNAO/B/G family, known to integrate signals between receptors and effector proteins, 
and the PPP1C genes involved in the regulation of cellular processes. Genes at the 
intersection of dopamine and opiate addictions included three PRKAC genes coding 
 
Figure 5: Genes shared between dopamine, opiate and GABA addiction sets. 
The figure provides the gene symbols for intersections of gene sets corresponding to 
dopamine, opiate, and GABA addictions.   
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cAMP-based signaling molecules; five genes from the CES gene family, responsible for 
the hydrolysis of xenobiotics; and two genes from the CDK family, cyclin-dependent 
kinases, implicated in neuronal growth and repair. The overlap of the dopamine and 
GABA addiction gene sets included two genes from the MMP family, involved in the 
breakdown of extracellular matrix. These results indicate that literature curated addiction 
genes under consideration were involved in diverse processes required of addiction  
 
Identification and annotation of addiction hotspots on the human genome 
The addiction gene list consisting of 587 genes for the three types of addiction was 
mapped onto the human genome. Most of the addiction genes were dispersed through 
the genome but 63 addiction genes mapped onto seven genomic hotspot regions, all 
less than 1.5 Mb, the typical length for a genetic recombination unit on human 
chromosomes (Figure 6). All these hotspots had at least six or more addiction genes. 
The statistical significance of finding the number of genes in each hotspot was 
calculated using hypergeometric tests for each chromosome. 
Three of the seven hotspots contained genes exclusively associated GABA addiction 
while the remaining four hotspots contained genes involved in GABA, dopamine, and 
opiate addictions (Figure 6). For each hotspot, we cataloged the co-located genes in the 
hotspots not yet identified as addiction-related. These additional genes represent 
candidates for further investigation. Hotspot windows contained 14 to 58 genes, with the 
number of addiction genes ranging from 6 to 19 curated genes located in a hotspot 
interval. The lists of genes in each hotspot are shown in Figure 6, with ones already 
linked to addiction shown in bold.  
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In addition to examining the distribution of those genes that existed in relatively short 
linear spaces, denoting the possibility for shared regulation across the genome, we also 
conducted hypergeometric tests to determine the statistical significance associated with 
these cluster of genes. Table 2 reports the hypergeometric values per hotspot location. 
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Table 2: Hypergeometric Analysis of the Addiction Hotspots identified along the Genome.  The seven 
hypergeometric values were calculated as a measure of genomic hotspots significance. 
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Figure 6: Hotspots participating in acute and chronic alcoholism pathways. The 
alcohol addiction pathway contains genes located in all seven of the addiction hotspots, 
each are colored according to the legend.  They participate in post-synaptic processes in 
both acute and chronic alcohol signaling. Additionally each component in the alcoholism 
pathway has a bar above the gene/component indicating their involvement in dopamine, 
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The hotspot gene lists were used to identify gene ontology biological processes and 
molecular functions enriched for each hotspot. Table 3 summarizes the results. The 
hotspot on chromosome 4 for GABA addiction is dominated by metabolic processes and 
enzymes. The GABA hotspot at chromosome 6 is crowded by genes involved in 
nucleosome assembly and DNA packaging. The GABA hotspot adjacent is also 
dominated by DNA binding proteins. The genes crowding the mixed hotspot on 
Chromosome 10 are involved in oxidation reduction and steroid metabolic processes.  
This hotspot has a series of neurological function genes that regulate appetite during 
stress in the brain and neuro-epithelial remodelers.  
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Table 3: Addiction genes within hotspots show distinct functional classification. 
The table shows the gene ontology molecular functions and biological processes 
statistically enriched in addiction hotspots (Benjamini coefficient < 0.03). Annotations in 
bold correspond to the addiction genes identified within a cluster and not the entire 
genome region. 
 
Region Biological Processes Molecular Function 
 Chr 
Location 
Functional 
Annotation 
Benjimani Functional 
Annotation 
Benjimani 
4q23 4:100Mb-
100.9Mb 
Ethanol metabolic 
process 
5.0E-9 Alcohol dehydrogenase  
activity 
2.9E-7 
 GABA 
Only 
 Ethanol oxidation 5.0E-9   
  
 Alcohol metabolic 
process 
5.0E-9   
  
     
6p22.2 6:25.7Mb-
26.4Mb 
Nucleosome assembly 3.2E-9 DNA binding 5.6E-3 
GABA 
Only 
 DNA packaging 3.4E-9 Ion membrane 
transporter activity 
7.5E-5 
 
 Chromosome 
organization 
1.8E-6 Alkali metal ion binding 7.5E-3 
  
     
6p22.1 6:27.8Mb-
28.9Mb 
Nucleosome assembly 2.9E-8 DNA binding 1.0E-3 
GABA 
Only 
 DNA packaging 2.2E-8   
  
 Chromosome 
organization 
1.3E-5   
  
     
10p15.1 10:5Mb-6Mb Oxidation reduction 1.8E-2 Steroid dehydrogenase 
activity 
1.5E-6 
Mixed  Steroid metabolic 
process 
2.8E-2 Trans- 1,2-
dihydrobenzene -1,2-
diol dehydrogenase 
activity 
5.7E-6 
    Aldo-keto reductase 
activity 
7.5E-5 
  
     
11q13.2-3 11:67Mb-
68.5Mb 
None NA Aldehyde 
dehydrogenase  activity 
3.6E-2 
Mixed 
     
  
       
16q22.1 16:55.5Mb-
57Mb 
None NA 
Cadmium ion binding 1.8E-16 
Mixed 
   Cation binding 2.2E-5 
 
   Transition metal ion 
binding 2.7E-3 
    
  
19q13.33 
Mixed 
19:48.8Mb-
49.9Mb 
Cell-cell signaling 0.02 Hormone activity 0.03 
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The hotspot in Chromosome 11 has multiple genes involved in actin creation/dynamics, 
cell development/differentiation, and lipid metabolism. The 16q22.1 locus has 
metallothionein genes involved in metabolism of xenobiotics. The 19q33.33 locus 
contains genes mediating spermatogenesis, hormone activity and signaling. It is clear 
from these results that addiction hotspots contain genes with complementary functions.  
 
The genes at the seven addiction hotspots were mapped onto KEGG cellular pathways.  
We found consistent participation of hotspot genes in pathways involved in neurological 
signal transmission. Figure 7 illustrates the roles that hotspot addiction genes play in 
canonical addiction pathways. The acute and chronic alcoholism pathways are heavily 
influenced at the post-synaptic neuronal cells by genes contained in all seven of the 
hotspot regions. The pathway contains genes that carry out the two major mechanisms 
of addiction regulation: neurotransmission remodeling and epigenetic modifications. The 
major pathways involved in dopaminergic and morphine addiction also show 
participation of genes with neurotransmitter molecular functions and synaptic 
transmission biological processes. It is clear from Figure 7 that genes belonging to 
different hotspots coordinate to function in cellular pathways involved in addiction.  
46 
 
 
 
Addiction hotspots exhibit population subtype dependent polymorphisms 
The presence of addiction hotspots on human chromosomes allowed us to identify 
genomic variation at shared polymorphism within a hotspot for the HapMap populations.  
We found significant differences in allelic distributions both among populations and from 
the population specific versus neutral comparisons.  When population specific allele 
frequencies were sorted into frequency bins, we were able to see whether the shape of 
their distributions were uniform, had an excess of high or low frequency alleles as 
compared to the neutral distribution (Figure 8).  As explained in the methods section, 
 
Figure 7: Hotspots participating in acute and chronic alcoholism pathways. The 
alcohol addiction pathway contains genes located in all seven of the addiction hotspots, 
each are colored according to the legend.  They participate in post-synaptic processes 
in both acute and chronic alcohol signaling. Additionally each component in the 
alcoholism pathway has a bar above the gene/component indicating their involvement 
in dopamine, GABA or opiate addiction. 
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the hotspot polymorphism distributions were then tested against the natural loci using 
the nonparametric Kolmogorov-Smirnov Test. Only the distributions with gray-scaled 
lines were not significantly different than the polymorphisms found in the neutral loci (p 
< 0.01). To better visualize these patterns, we generated the heat maps shown in Figure 
9 based on the p values obtained in population comparisons for each hotspot. The 
hotspot identified at 6p21.2 (25.7 – 26.4 Mb) in this figure shows considerable similarity 
on polymorphisms for populations from the same origin, Africa, Asia, Europe. This 
appears to be particularly true for the Chinese of Beijing (CHB), Chinese of Denver 
(CHD) and Japanese of Tokyo (JPT) populations who are significantly different in 
polymorphism expression from all non-Asian populations. These results indicate 
addiction hotspots at chromosome 6 as loci with polymorphisms highly dependent on 
population subtypes.  
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Responding to results observed in Figure 7, shared polymorphisms at each addiction 
hotspot region was grouped by population regional ancestry – Asian, African, and 
European so that we could make comparisons between these ethnic types. The 
population comparison is illustrated in Figure 8 for SNPs along the hotspots.  Figure 10 
shows quite a few SNPs in all addiction hotspots deciphered in this study have altered 
allele frequencies between Asian, African, and European populations, with the chi-
squared test (p < 0.01) in region level comparisons. The accompanying Table 4 
identifies significant SNPs along the hotspot 6p21.2 (25.7 – 26.4 Mb) for the three 
 
Figure 8: Allelic distributions at addiction hotspots show population and 
regional variation. Each graphic considers polymorphism distributions of addiction 
hotspots against the neutral distribution (in red). Hotspot distributions were tested 
against the neutral loci using the non-parametric Kolmogorov-Smirnov test. 
Distribution graphs with grey-scaled lines are those not significantly different from the 
neutral distribution.  
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population comparisons.  A large portion of these SNPs falls onto the intron regions of 
histone genes known to have roles in addiction. But three others fall onto the gene 
SLC17A4, which codes a sodium/phosphate co-transporter in the intestinal mucosa. 
The protein plays an important role in the absorption of phosphate from the intestine 
and its possible role in addiction is yet to be determined. Table 4 also shows five 
intergenic variants identified as significantly varying between these populations 
(rs6906576, rs6924948, rs7740793, rs9348699, rs933199). When the frequencies of 
significant polymorphisms identified through GWAS studies (Table 5) were examined, 
we found that there are strong allele frequency differences when populations were 
considered by region of origin. In particular we noted that rs8040009, rs2154294, 
rs2827312, rs6701037, and rs1109501 showed allele frequencies that differentiated 
East Asians from non-East Asian populations. Two alleles differentiate Europeans from 
non-European populations: rs2140418 (alcoholism- alcohol use disorder) and 
rs10908907 (alcoholism- heaviness of drinking).  
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Figure 9:  Heat maps of SNP distribution on hotspots show population and 
geographical Patterning.  Comparisons of the average reference allele frequencies 
are shown for each addiction hotspot across populations using -log10 of the p values 
obtained from the Kolmogorov-Smirnov test. The variation in neutral regions shows very 
little demographic patterning while the hotspot located at Chr6: 25.7-26.4 shows 
considerably more regional blocks.  
 
 
 
 
 
Figure 10: Hotspot SNPs with significantly altered expression in regional 
population subtypes. Significant polymorphisms were found for regional population 
comparisons between African-Asian (N=112), African-European (N=126), and 
European-Asian (N=122) using chi squared test with a p value cutoff of 1e-5 as shown 
by the blue line in the figure. The value for the red line cut off is 5e-8. 
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SNP   Africans Asians European  Other P values 
GENE TYPE MKK LWK YRI ASW CHB CHD JPT CEU TSI GIH MEX African-
Asian 
African-
European 
Asian-
European 
rs1800708 HFE intron 0.029 0.083 0.088 0.07 0.456 0.445 0.319 0.08 0.05 0.2 0.149 4.04E-01 9.69E-01 1.47E-07 
rs9366637 HFE Intron  0.045 0.077 0.075 0.079 0.493 0.495 0.385 0.066 0.059 0.173 0.216 3.96E-01 9.17E-01 2.57E-10 
rs2237231 HIST1H1A downstr. 
500B 
0.054 0.077 0.075 0.088 0.489 0.5 0.389 0.084 0.059 0.193 0.216 4.01E-01 9.78E-01 5.82E-08 
rs9393682 HIST1H1C upstr. 2KB 0.042 0.077 0.075 0.079 0.485 0.5 0.389 0.066 0.059 0.203 0.216 3.95E-01 9.27E-01 2.48E-10 
rs2051542 HIST1H1T missense 0.029 0.082 0.088 0.07 0.46 0.445 0.319 0.08 0.054 0.198 0.164 4.04E-01 9.97E-01 3.59E-07 
rs3830054 HIST1H2AB upstr. 2KB 0.042 0.077 0.075 0.088 0.496 0.5 0.389 0.084 0.059 0.203 0.216 3.97E-01 9.89E-01 4.85E-08 
rs6908263 HIST1H2AC intron 0.141 0.114 0.136 0.105 0.46 0.45 0.319 0.08 0.064 0.198 0.172 4.86E-01 4.70E-01 2.73E-06 
rs7760713 HIST1H2AC intron 0.138 0.114 0.139 0.105 0.463 0.449 0.321 0.076 0.064 0.193 0.216 4.85E-01 4.40E-01 1.11E-06 
rs9467684 HIST1H2BD intron 0.179 0.132 0.153 0.149 0.011 0.005 0.08 0.013 0.025 0.035 0.017 1.51E-04 1.60E-12 4.94E-01 
rs4145878 HIST1H2BF upstr.2KB 
intron 
0.391 0.405 0.412 0.404 0.106 0.092 0.018 0.5 0.495 0.381 0.414 4.28E-06 8.49E-01 3.92E-01 
rs1892252 SLC17A4 intron 0.362 0.232 0.248 0.316 0.051 0.032 0.075 0.133 0.098 0.03 0.172 6.90E-06 1.32E-01 5.86E-01 
rs3734525 SLC17A4 utr 3’ 0.106 0.186 0.211 0.193 0.007 0.005 0.075 0.004 0.01 0.005 0.017 5.73E-07 0.00E+00 1.67E-03 
rs3823151 SLC17A4 intron 0.388 0.336 0.35 0.272 0.099 0.087 0.111 0.04 0.049 0.03 0.078 1.64E-02 5.32E-11 2.21E-01 
rs199738 TRIM38 utr 5’ 0.337 0.403 0.445 0.36 0.074 0.046 0.053 0.19 0.157 0.183 0.147 1.21E-08 2.20E-01 5.04E-01 
rs6906576 intergenic genomic 0.074 0.114 0.175 0.14 0.391 0.408 0.35 0.058 0.039 0.183 0.241 5.02E-01 1.11E-01 5.31E-12 
rs6924948 intergenic genomic  0.023 0.028 0.028 0.035 0.485 0.495 0.386 0.076 0.054 0.215 0.207 3.49E-01 5.74E-01 1.91E-09 
rs7740793 intergenic genomic 0.122 0.114 0.19 0.149 0.391 0.408 0.35 0.058 0.039 0.175 0.241 5.32E-01 4.95E-02 5.31E-12 
rs9348699 Intergenic genomic 0.122 0.114 0.19 0.149 0.391 0.408 0.35 0.058 0.039 0.183 0.241 5.32E-01 4.95E-02 5.31E-12 
rs933199 intergenic  genomic 0.03 0.083 0.091 0.07 0.459 0.445 0.319 0.082 0.054 0.203 0.17 4.05E-01 9.94E-01 5.88E-07 
  
Table 4: SNPs identified as significant in comparisons between Africans, Asians and Europeans for the 6p21.2 
addiction hotspot. All SNPs were tested for significant differences in allele frequencies using a chi square test (cutoff < 
1e-5) in pairwise regional comparisons: Africans (ASW, YRI, LWK, and MKK), Europeans (CEU and TSI), and Asians 
(CHB, CHD, JPT). The Allele frequencies of variants in populations are given with the p values of the grouped regional 
ethnic populations. 
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Africans Asians Europeans S Asian American 
Alcohol 
Dependence 
GWAS ID SNP ID CHR Location pValue Allele MKK LUH YRI ASW CHB CHD JPT CEU TSI GIH MEX 
HGVRS1526 rs6701037 1 1.75E+08 2E-07 C 0.369 0.372 0.3 0.316 0.098 0.065 0.1 0.518 0.369 0.318 0.27 
HGVRS1526 rs750338 11 1.25E+08 0.000001 0.332 0.417 0.52 0.378 0.598 0.559 0.54 0.177 0.244 0.273 0.18 
                                    
Alcoholism, 
alcohol use 
disorder factor 
score 
HGVRS1536 rs6716455 2 1.51E+08 7E-07 G 0.895 0.978 1 0.969 0.817 0.869 0.76 0.845 0.787 0.898 0.83 
HGVRS1536 rs9556711 13 98016416 0.000002 G 0.5 0.356 0.34 0.449 0.78 0.735 0.87 0.929 0.943 0.909 0.91 
HGVRS1536 rs2140418 6 34975415 0.000004 C  0.44 0.283 0.39 0.541 0.439 0.359 0.48 0.774 0.784 0.568 0.76 
HGVRS1536 rs768048 18 50285398 0.000008 C  0.476 0.376 0.53 0.592 0.988 0.97 0.97 0.838 0.947 0.892 0.91 
                                    
Alcoholism, 
heaviness of 
drinking 
HGVRS1537 rs9512637 13 27920611 1E-07 C 0.591 0.411 0.39 0.347 0.232 0.282 0.16 0.673 0.591 0.443 0.42 
HGVRS1537 rs8040009 15 93044339 3E-07 T 0.461 0.443 0.31 0.385 0.812 0.859 0.84 0 0.807 0.949 0.76 
HGVRS1537 rs1109501 4 71329490 0.000005 G 0.88 0.906 0.97 0.929 0.573 0.559 0.55 0.741 0.636 0.756 0.68 
HGVRS1537 rs10908907 9 92249584 0.000006 G 0.413 0.356 0.26 0.357 0.527 0.421 0.5 0.739 0.619 0.339 0.44 
HGVRS1537 rs2827312 21 23631676 0.000008 G 0.542 0.689 0.56 0.664 0.915 0.946 0.91 0.628 0.551 0.648 0.63 
HGVRS1537 rs195204 1 1.16E+08 0.000009 T 0.86 0.9 0.91 0.857 0.537 0.624 0.5 0.765 0.773 0.562 0.65 
                                    
Alcoholism, 
12-mth wkly 
alc. consum. HGVRS1538 rs2154294 14 42655275 0.000003 G 0.462 0.456 0.56 0.561 0.744 0.835 0.84 0.549 0.545 0.591 0.57 
                                    
Alcohol 
dependence 
HGVRS1539 rs9556711 13 98016416 8E-07 G 0.5 0.356 0.34 0.449 0.78 0.735 0.87 0.929 0.943 0.909 0.91 
HGVRS1539 rs2140418 6 34975415 0.000004 C 0.44 0.283 0.39 0.541 0.439 0.359 0.48 0.774 0.784 0.568 0.76 
HGVRS1539 rs10253361 7 1.21E+08 0.000006 T 0.727 0.917 0.83 0.776 0.293 0.376 0.47 0.562 0.523 0.477 0.51 
HGVRS1539 rs933769 15 96052742 0.000007 T  0.839 0.872 0.96 0.898 0.634 0.72 0.61 0.867 0.807 0.642 0.77 
                                    
Alcohol 
dependence HGVRS1742 rs8062326 16 19156016 0.000004 T  0.115 0.078 0.08 0.082 0 
no 
data 0 0.031 0.034 0.028 0.06 
Table 5:  GWAS derived Addiction Alleles showed significant differences in allele frequencies between Asians 
and Non-Asian populations. Alleles identified as significant in GWAS studies were typed in the 11 HapMap populations. 
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Distant connections of hotspot polymorphisms  
We followed these frequency-based analyses of hotspots with analysis uncovering 
linkage to distant sites. For this purpose we used the web platform GWAS3D 
developed recently by Jun Li M et al. (109). The platform identifies genetic variants 
affecting regulatory pathways and underlying disease/trait associations by 
integrating chromatin state, functional genomics, sequence motif, and conservation 
information given a variant list. In the addiction case under study, we examined the 
distant regulatory landscape through linkage of the significant SNPs identified at 
hotspots in cross population comparisons.  
 
Figure 11 shows the significant common variants between Africans and Europeans 
projected onto the Yoruba population. In the outer ring, polymorphisms or genomic 
regions are identified. The second ring identifies the genes or chromosomal regions 
these polymorphisms sit in and finally the red lines indicate the strength of local or 
long range interactions. Thus, with the use of emerging bioinformatics web 
platforms, deciphering addiction hotspots on the human genome show potential for 
further discovery of DNA motifs distant to the hotspots. 
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Figure 11: Significant SNPs characterized in the Yoruba population show local and 
long range interactions. Polymorphisms identified as significant in African to European 
comparison were projected onto the GWAS3D platform.  At least six long-range trans-
chromosomal interactions were identified and numerous local interactions were 
observed. 
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DISCUSSION 
 
The NCBI Gene web platform recently began providing gene lists associated with 
disease or disorders, ordered according to prevalence in literature searches. Some 
of the genes in the list were inferred from genome wide association studies.  The 
others were derived from research focusing specific targets. Using NCBI curated 
gene lists, we investigated the biological processes and cellular pathways involved 
in three types of addiction: addiction linked to dopamine (cocaine and crystal 
methamphetamine), opiate (heroine and morphine), and GABA (Alcohol and GHB).  
Biological process annotations could be sorted into three categories. Those involving 
all addiction classes included neurological, behavioral and cell signaling function. 
Processes common to dopamine and opiate addiction included signal transduction, 
neurological system process, and transport. GABA specific processes, on the other 
hand, consisted of chromatin assembly, organization and homeostatic processes.    
 
The gene molecular functions involving all addiction classes included ion channel 
activity, receptor function and binding.  Those involved in dopamine and opiate 
addiction largely consisted of anion binding, kinase activity and channel regulation. 
Molecular functions specific to GABA addiction involved DNA binding, hormone 
activity, and deacetylase activity. These findings indicate that the differentiating 
mechanisms of GABA addiction from opiate and dopamine addictions all involved 
chromatin remodeling. Some of the addiction genes specific to GABA addiction, 
histone genes, are known to mediate methylation events, suggesting epigenetic 
modifications be an important component of alcohol addiction.      
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Recent studies point to hotspots on human chromosomes, where disease related 
genes clustered (111).  Similarly, a meta-analysis of GWAS studies on aging led to 
discovery of a number of disease hotspots on the human genome. Other studies 
indicate the presence of foci for susceptibility to autism (112).  Taking inspiration 
from these studies, we mapped the addiction gene lists onto human chromosomes 
and demonstrated the existence of addiction hotspots on the human genome. About 
11 percent of literature-curated addiction genes formed seven clusters of 6 or more 
genes within a span of 1.5 Mb, a typical length for genetic variation, along the 
chromosomes. The DNA segments containing the clusters were deemed as 
hotspots.  
 
The addiction hotspots fell onto chromosomes 4, 6, 10, 11, 16, and 19. 
Chromosome 6 contained two hotspots in close vicinity at 6p21.2. All hotspots also 
contained genes not previously linked to adhesion, gene regulatory motifs and 
polymorphisms. Three of the seven addiction hotspots (ones on chromosomes 4 and 
6) were related exclusively to GABA addiction, one on chromosome 4 linked to 
alcohol metabolic processes, and the two on chromosome 6 related to chromatin 
packaging and ion membrane transport.  The rest were mixed. The hotspot on 
chromosome 10 was related to steroid metabolism whereas the hotspot on 19 
exhibited cell-cell signaling through hormone activity. Overall, the genes in addiction 
hotspots crowded the canonical addiction pathways. The addiction hotspot gene list 
was also enriched in pathways for systemic lupus erythematous, viral 
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carcinogenesis, and steroid hormone biosynthesis, suggesting susceptibility of the 
addicted to other disease and disorders. The functional pleiotropic nature of these 
hotspots helps to explain how addiction creates a spectrum of disorders that are not 
limited to particular addictive substance (113, 114).  
 
The presence of hotspots on the human genome provides an opportunity for 
discovery of addiction related genes. Addiction genes accounted for a significant 
percentage of total genes (> 36 %) in the three hotspots exclusively related to GABA 
addiction with nearly all genomic regions containing near statistically significant or 
statistically significant numbers of NCBI identified genes within the hotspot region. 
The other four mixed hotspots contained a vast majority of genes not currently linked 
to addiction.  Consider for example, the gene RG9MTD2 in the GAMA only hotspot 
on Chromosome 4.  This gene codes a RNA transmethylase, expressing an 
acetaminophen-binding site. Acetaminophen has been shown to increase feelings of 
intoxication in combination with ethanol in a human cohort and does not mitigate 
subjective feelings of alcohol intoxication (115).  
 
Additionally, our mixed addiction hotspot located at Chr19 sits adjacent to the Killer 
cell Immunoglobulin-like Receptor (KIR) genomic region. This foci displays extensive 
diversity through allelic polymorphism within individual KIR genes(116). It is possible 
to speculate that the regulatory changes in our identified hotspot could change the 
regulatory landscape for the KIR region.  Another family of genes with potentially 
important roles (yet to be defined) is the SLC17A1-4 genes coding organic ion 
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transporters in a GABA only hotspot on Chr6.  These genes were identified as 
having storage activity (117) for neurotransmitters playing crucial roles in addiction 
(32). 
 
Addiction hotspots showed ethnic population dependent polymorphisms. We have 
identified polymorphism in hotspots, which significantly varied among the 11 ethnic 
HapMap populations. Pooling these populations by their geography of origin (East 
Asian, African, and European) allowed us to achieve a regional perspective of the 
importance of ethnic origin in future analyses at the genetic and epigenetic 
interactions. Our population-based variation analyses found significant population 
variation at the 6p21.2 region, which differentiated HapMap Chinese and Japanese 
populations from all other non-Asian populations. Analysis brought to light SNPs that 
fall onto histone and SLC genes, as the major differentiating factors. It is clear that 
the 6p21.2 locus is a potentially potent source of genetic variation that could help 
explain the phenotypes variation between East Asian and non-Asian populations. 
Additionally the Yoruba (Nigerian population) have unique signals of population 
variation at 4q23 and 6p21.1.  Additional analyses of addiction GWAS 
polymorphisms in HapMap populations showed similar patterns to those we saw in 
our dataset. This pattern showed strong East Asian to non-East Asian population 
differences in commonly shared allele frequencies. We believe that this observation 
supports our finding that the polymorphism analyses we perform here are 
representing some genomic phenomenon in Asian populations.  The list of candidate 
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polymorphisms presented in Table 3 may become substrates future association 
analyses.  
 
The gene contents of GABA only addiction hotspots suggest an epigenetic role in 
alcohol addiction (84, 118-120). The two hotspots on Chr6 are highly enriched with 
histone genes. It is well established that methylation state of histone proteins are 
directly related to genes in DNA being "off" or "on". Functional annotation shows 
histone involvement in non-addiction related KEGG pathways such as systemic 
lupus, viral carcinogenesis and transcriptional mis-regulation of cancer. In fact, 
histone protein modification through methylation has been identified as one of the 
possible reasons for the diverse phenotypes seen in addicted individuals (114, 121, 
122). The SNPs in histone genes on Chr6 may lead to alternate epigenetic 
modifications among ethnic population, a result previously seen in other 
datasets(123). Moreover, our GWAS3D analyses found that 6p21.2 SNPs identified 
as significant in our cross population assessments were also involved in local and 
trans-chromosomal interactions. Potential links between hotspots and addiction 
genes dispersed on human chromosomes merit further investigation.  
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Specific Aim II: Addiction and Mental Health  
Introduction  
Addiction disorders represent a major economic and health cost to human 
populations (51). Addiction is loosely defined as a chronic relapsing spectrum 
disorder characterized by loss of control over substance taking (52-54). Similarly, 
neurological disorders such as depression, bipolar disorder, and schizophrenia 
represent a significant strain on health and judicial entities. Both disorder classes 
have long been identified as co-morbidities (124). Both Substance addiction and 
mental health are behavior-based phenomenon representing a diverse array of 
psychological, biological, and genetic attributes and environmental and cultural 
factors (32, 33, 55-57).   
 
A number of studies have identified the clinical intersection of mental health and 
substance addiction traits (125, 126). This has been shown in a diverse variety of 
mental health conditions such as depression (127, 128), bipolar disorder (129-131), 
and schizophrenia (132-137). To date, the crosstalk of addiction and mental health 
genetic contributors has not been fully understood based on association studies (68, 
138) and functional genomics (41, 42). Studies show that drugs targeting specific 
mental health conditions such as schizophrenia have  
 
In this study we focus on the addiction disorders for opiate, dopamine, and GABA 
addiction as well as the mental health disorder identified as depression, bipolar 
disorder and schizophrenia. We map literature curated addiction and mental health 
genes onto human chromosomes. Clusters of these genes identify hotspot locations 
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within the genome.  These hotspots contain genes previously not linked to addiction 
and mental health as well as regulatory motifs with drug binding sites. Our 
bioinformatics based discovery and subsequent investigation of combined addiction 
and mental health hotspots reveal their functional roles. Results point out multiple 
hotspots participating in dual addiction and mental health phenotypes.     
 
Specific Aim II: Assessing the genomic regions sitting at the intersection of 
Addiction and Schizophrenia, Bipolar Disorder and Depression disorders and 
their interplay with drug binding sites. 
 
I hypothesize that when Addiction and mental health loci are jointly considered, we 
can identify hotspots for their interactions. A number of studies have identified the 
clinical intersection of mental health and substance addiction traits (125, 126). This 
has been shown in a diverse variety of mental health conditions such as depression 
(127, 128), bipolar disorder (129-131), and schizophrenia (132-137). To date, the 
crosstalk of addiction and mental health genetic contributors has not been fully 
understood based on association studies (68, 138) and functional genomics (41, 42).  
 
Methods 
Addiction linked genes and genome hotspots 
A search of NCBI Gene based on strings of disease words was used in order to 
generate a list of genes with biological relevance to addiction. We focused on 
dopamine, opiate and GABA addiction; bipolar disorder; depression; and 
schizophrenia. We mapped the resulting list of genes onto human chromosomes 
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and considered the clusters they form.  Then, we wrote a Matlab based program to 
cluster genes in the genome and report those hotspot regions back as an output file.   
 
Hotspots were defined as genic regions approximately 2 Mb in length along the 
genome, which contained 13 or more genes identified from our combined addiction 
and mental health gene list. These hotspot regions were elongated from those 
identified in specific aim I to accommodate the differences in recombination rate 
found in genomic regions and the starting number of genes in the initial gene list. 
Additionally we collapsed multiple small genomic hotpot windows into larger ones 
that spanned the 2Mb or smaller region. Each hotspot contained genes not currently 
associated with these joint addiction and mental health phenotypes.  We included 
such genes into our analysis due to high probability of common regulation patterns 
within a hotspot. Next we investigated the statistical significance of observing 18 or 
more genes as hotspots, given a starting number of addiction and mental health 
associated genes.  
 
Functional Annotation of Addiction and Mental Health Hotspot Genes  
Genes located within hotspots were considered in two ways in statistical 
enrichments: all genes in the hotspot window, and only those previously linked to 
addiction.  All genes in the hotspots were annotated using DAVIDs Bioinformatics 
Resources Tool software (101, 102) for biological process, molecular function, cell 
compartment and KEGG pathways (46, 49). Functional enrichments were quantified 
using Benjamini score analysis cutoffs of 0.01 (103). Finally, all genes in hotspots 
were annotated for drug interactions using Drug Bank (139-142). 
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Results 
Overlap in Gene Lists for Addiction, Schizophrenia, Bipolar Disorder and Depression 
We conducted searches to identify genes belonging to NCBI curated mental health 
and addiction genes lists. The bipolar disorder gene list comprised 626 genes, 
depression comprised 357 genes, schizophrenia comprised 1121 genes and 
Addiction comprised 587 genes garnered from opiate, GABA and dopamine 
addictions. When considered together this genes list represented 1968 genes 
encoding putative addiction and mental 
health
targets. Figure 12 is a Venn diagram that shows the overlap in genes from these 
four gene lists. Interestingly, there were 51 genes that were shared between all gene 
lists but only four of these shared genes were represented in the eight hotspots. 
These are indicated in red in Table 6. This overlap gene set contained the DRD, 
 
Figure12: Genes shared between dopamine, opiate and GABA addiction 
sets with common mental health conditions. The Venn diagram provides the 
gene symbols (N=1968 genes) for intersections of gene sets corresponding to 
dopamine, opiate, and GABA addictions with bipolar disorder, depression, and 
schizophrenia.  The gray boxed genes are those genes common to all disorders. 
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HTR and SLC6A gene families as well as a host of immune function genes 
including: ICAM1, IFNG, IGF1, IL1B, IL1RN, and TNF. Of this combined set of 
addiction and mental health genes, 192 genes fell into cluster regions within the 
genome.  Our analyses identified these eight genomic regions with significant 
numbers of genes involved in the dual disorders.  
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Chr Location N NCBI Identified Genes Candidate Interspersed Genes 
2 98444858- 99400475 13 INPP4A, MGAT4A, KIAA1211L, TSGA10, C2orf15, LIPT1, MITD1, MRPL30, 
LYG2, LYG1, TXNDC9, EIF5B, REV1 
C2orf64, UNC50 
3 51,741,081-53,752,625 33 GRM2, ALAS1, TLR9, TWF2, PPM1M, WDR82, GLYCTK, DNAH1, BAP1, 
PHF7, SEMA3G, TNNC1, NISCH, STAB1, NT5DC2, PBRM1, GNL3, 
SNORD19, SNORD19B, SNORD69, GLT8D1, SPCS1, NEK4, ITIH1, ITIH3, 
ITIH4, MUSTN1, TMEM110, SFMBT1, RFT1, PRKCD, TKT, CACNA2D3 
IQCF6, IQCF1, IQFC4, IQFC3, IQFC2, IQFC5, RRP9, PARP3, 
PCBP4, ACY1, ABHD14B, LINC00696, DUSP7, POC1A 
6 25782897-27450742 28 SLC17A3, HIST1H3A, HIST1H4B, HIST1H3B, HIST1H3C , HIST1H2AE, 
HIST1H3E,HFE, HIST1H3E, ,  HIST1H2BE, HIST1H4D, HIST1H4C, 
HIST1H3D, HIST1H3F, HIST1H4E,  HIST1H4F HIST1H3G, BC079832, 
HIST1H4H BTN3A2, BTN2A2, BTN3A1, HIST1H2BJ, HIST1H2AG, 
PRSS16, POM121L2, ZNF184 
 SLC17A2, TRIM38, HIST1H2AB, HIST1H1C, HIST1H1T, 
HIST1H2BC, HIST1H1E, HIST1H2AC, 
HIST1H2BDHIST1H2AD, HIST1H2BF, , HIST1H2BG, 
HIST1H1D, , HIST1H4G, HIST1H2BH, HIST1H2BI,BTN1A1, 
ABT1, ZNF322A, HIST1HBK, HIST1H41 
6 30,184,455-33621379 31 HLA-E, TUBB, LINC00243, DDR1, HLA-C, HLA-B, MICB,  LTA, TNF, 
PRRC2A, BAG6, HSPA1L, HSPA1A , HSPA1B, TNXB, ATF6B, RNF5, 
AGER, NOTCH4, HCG23, HLA-DRA, HLA-DRB1, HLA-DQA1,  HLA-DQB1, 
RXRB, KIFC1, PHF1, SYNGAP1, ITPR3 
ABCF1, PPPI110, MRPS18B, C6ORF134, DHX16, KIAA1949, 
MDC1,FLOT1, IER3, GTF2H4, VARS2, SFTA2, DPCR1, 
MUC21, CCHCR1, PSORS1C1, CDSN, TCF19, POU5F1, 
HCG27,  
11 64,803514- 66,033,706 22 MEN1, CAPN1, CDC42EP2, RELA, CFL1, GAL3ST3, SF3B2, PACS1, 
KLC2, RAB1B, CNIH2, YIF1A, TMEM151A, CD248, RIN1, BRMS1, 
B3GNT1, SLC29A2, NPAS4, MRPL11, PELI3, DPP3 
EHD1, ATG2A, PPP2R5B, GPHA2, BATF2, ARL2, ARL2-
SNX15, SAC3D1, NAALADL1, ZFPL1, TM7SF2, ZNHIT2, 
MRPL49, SYVN1, CDCA5, FAU, SPDYC, SLC22A20, POLA2, 
DPF2, TIGD3, FRMD8, SLC25A45, MALAT1,SCYL1, KCNK7, 
LTBP3,SSSCA1, FAM89B, EHB1L1, MAP3K11, PCNXL3, 
SIPA1, KAT5, CATSPER1, EIF1AD, TSGA10IP, C11orf68, 
FOSL1, EFEMP2, MUS81, SART1, FIBP, SNX32, AP5B1, 
BANF1, CST6 
11 66,034,695- 68008578 22 BBS1, ZDHHC24, ACTN3, CTSF, CCDC87, CCS, RBM14, RBM4, RBM4B, 
SPTBN2, C11orf80, RCE1, PC, LRFN4, C11orf86, SYT12, ADRBK1, 
CABP4, GSTP1, NDUFV1, ALDH3B2, ALDH3B1 
TBX10, NUDT8, DOC2GP, X15673, AK129926, ACY3, 
C11orf72, AIP,CDK2AP2, PITPNM1, TMEM134, CORO1B, 
GPR152, TBC1D10C, PPP1CA, RAD9A, POLD4, CLCF1, 7SK, 
CARNS1, PTPRCAP, RPS6KB2, SSH3, ANKRD13D, KDM2A, 
RHOD 
19 48047843- 49429398 27 SULT2A1, PLA2G4C, GRIN2D, SULT2B1, FAM83E, RPL18, SPHK2, DBP, 
CA11, NTN5, FUT2, MAMSTR, RASIP1, IZUMO1, FUT1, FGF21, BAX, FTL, 
LHB, CGB, CGB2, CGB1, CGB5, CGB8, CGB7, NTF4, SLC17A7 
GRWD1, KCNJ14, CYTH2, LMTK3, SPACA4, BCAT2, 
HSD17B14, PPP1R15A, TULP2, PLEKHA4, NUCB1, GYS1, 
RUVBL2, KCNA7, LIN7B, PPFIA3, HRC, TRPM4, 
SLC16A16,CD37, TEAD2, DKKL1, PTH2 
22 18906223-21207972 18 PRODH, DGCR2, DGCR14, UFD1L, CLDN5, TBX1, GNB1L, COMT, 
ARVCF, DGCR8, TRMT2A, RANBP1, ZDHHC8, RTN4R, MED15, PI4KA, 
GGT2  
TSSK2, SLC25A1, CLTCL1, HIRA, MRPL40, C22ORF39, 
CDC45L, SEPT5, GP1BB, C22ORF29 
Table 6: Addiction, bipolar disorder, depression, and schizophrenia form eight genomic hotspots. When genes 
were mapped to the genome, we found eight regions smaller  than 1.5 Mb each with 11- 38 genes identified from NCBI 
Gene curated gene lists.  Additionally we consider the genes interspersed with our set of addiction and mental health 
genes. Red gene names are those that were among the 51 genes shared by all addiction and mental health disorders. 
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These eight regions are shown in Figure 13 with their associated NCBI-identified 
genes (green) and the candidate genes (black) that are interspersed. Hotspots 
ranged from having 13- 33 literature curated genes in a genomic window 
approximately 2Mb or smaller.  
 
 
Functional annotation of Schizophrenia, bipolar, depression and addiction genes 
We performed a functional annotation on the complete list of NCBI identified genes 
in order to determine the major functional roles for addiction and mental health 
genes. Functional annotation of the combined set of depression, schizophrenia, 
bipolar and addiction genes found commonalities as identified in Figure 14, with 
shared function revolving around neurological function, response organic 
 
Figure 13: Eight bipolar, depression, schizophrenia and addiction hotspots 
identified on the human genome. Each karyotype of a chromosome shows the location 
of the genes that are represents as hotspots. Genes that lie within each hotspot were 
identified through USCS Genome Browser. The insets for each hotspot show genes 
identifies curated genes (green) and interspersed genes (black) with a red band showing 
the entire hotspot region.  
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substances and cell-cell signaling. Addiction and depression overlapped in three 
functional regulatory roles: cellular localization, cyclic nucleotide biosynthesis and 
metabolism. Additionally when pairwise comparisons were made (not shown), 
depression and schizophrenia gene lists overlapped in homeostatic processes, while 
bipolar and schizophrenia genes jointly participated in neuronal development and 
cellular differentiation. Hotspot gene lists were used to identify gene ontology 
biological processes and molecular functions enriched for each hotspot. When we 
considered the identified literature curated genes that identified each hotspot and 
then those genes that were not previously identified, but could be addiction and 
mental health candidates, we found no real differences in the functional annotation 
of these sets.  
 
 
Numerous targets found in Hotspot windows 
Drug target annotation was performed to determine the role that pharmacological 
products interacted to binding sites within these hotspots.  When the hotspot regions 
were annotated for drug interactions 16 drugs were found to have binding sites. 
Addiction, bipolar, depression and schizophrenia drug interactions are characterized 
in Table 2.  
 
 
Figure 14: Gene ontology molecular function annotations for addiction, bipolar 
disorder, depression and schizophrenia. The top 25 significant functional annotations were 
obtained (Benjamini > 0.01) for gene ontology molecular function for each addiction, bipolar, 
depression, schizophrenia gene class. The vertical axis of each graph shows the –log10 (p) 
while the horizontal axis indicates the functional annotations. The gene lists are color coded 
for depression (green), bipolar disorder (red), schizophrenia (blue). Addiction genes are a 
composite of opiate, GABA, and dopamine addiction genes (purple).  Thirteen functions are 
shared between the gene sets. 
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Chr Gene Target Drug Drug Name Mechanism of Action Treatment Targets 
3:51 TLR9 DB0546
3 
ISS-1018 immunostimulatory activity.  *Hepatitis B, b-cell or non-
hodgkin’s lymphoma. 
TLR9 DB0490
0 
Thymalfasin unspecified Influenza  
Hepatitis B 
11:64 GSTP1 DB0433
9 
Carboxymethyl
ene-cysteine 
unspecified unspecified 
MTR, MTRR, 
MMACHC, 
MTHFR 
DB0011
5 
Cyanocobalami
n 
unspecified pernicious anemia 
vitamin B 12 deficiency 
11:66 TOP2A, 
TOP2B 
DB0077
3 
Etoposide unspecified refractory testicular tumors, 
small cell lung cancer, 
Lymphoma 
non-lymphocytic leukemia 
glioblastoma multiform 
DNA DB0100
8 
Busulfan selective immunosuppressive 
effect on bone marrow 
conditioning regimen prior to 
allogeneic hematopoietic, 
progenitor cell transplantation 
for chronic myelogenous 
19:48 bglA DB0465
8 
(1S,2R,3S,4R,5
S)-8-
AZABICYCLO 
[3.2.1]OCTANE
-1,2,3,4-
TETROL 
unspecified unspecified 
BCL2, BAD 
BBC6, 
BCL2L8  
DB0576
4 
ABT-263 It blocks some of the enzymes 
that keep cancer cells from 
dying. 
lymphomas and other types of 
cancer 
CYP17A1 DB0581
2 
Abiraterone derivative of steroidal 
progesterone  
hormone refractory prostate 
cancer. 
KCNJ 
PTGS1 
COX11,  
DB0035
0 
Minoxidil direct-acting peripheral 
vasodilator 
reduces peripheral resistance 
produces a fall in blood 
pressure 
BRAF1, 
RAFB1 FLT4, 
FLT3, 
VEGFR3,  
VEGFR2,  
DB0039
8 
Sorafenib small molecular inhibitor of Raf 
kinase, PDGF (platelet-derived 
growth factor), VEGF receptor 2 
& 3 kinases and c Kit the 
receptor for Stem cell factor 
advanced renal cell carcinoma 
advanced hepatocellular 
carcinoma  
PTGS2, 
COX2, 
PTGS1, 
COX1, 
DB0031
6 
Acetaminophe
n 
analgesic and antipyretic 
effects 
Therapeutic effects are similar 
to salicylates, but it lacks anti-
inflammatory, antiplatelet, and 
gastric ulcerative effects. 
22:18 COMT DB0032
3 
Tolcapone inhibits the enzyme catechol-O-
methyl transferase (COMT) 
Parkinson’s disease 
 COMT DB0049
4 
Encapone reversible inhibitor catechol-O-
methyl transferase  (COMT)  
Parkinson’s disease 
 COMT DB0145
4 
3,4-
Methylenedi-
oxymethamphe
tamine 
classified as a hallucinogen and 
causes marked, long-lasting 
changes in brain serotonergic 
systems It is commonly referred 
to as MDMA or ecstasy 
post-traumatic stress disorder 
(PTSD) and anxiety associated 
with terminal cancer 
 COMT DB0123
5 
L-DOPA naturally occurring form of 
dihydroxyphenylalanine and the 
immediate precursor of 
dopamine. Unlike dopamine 
itself, it can be taken orally and 
crosses the blood-brain barrier. 
It is rapidly taken up by 
dopaminergic neurons and 
converted to dopamine 
idiopathic Parkinson's disease 
(Paralysis Agitans), 
postencephalitic parkinsonism, 
symptomatic parkinsonism 
which may follow injury to the 
nervous system by carbon 
monoxide intoxication, and 
manganese intoxication 
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While not all hotspots had drug binding sites located within their domains, five of the 
hotspots did. When we identified the types of drugs found at these five hotspots we 
found some thematic divisions in drug targets. Five drug binding sites are associated 
with cancer therapies: Sorafenib, Abiraterone, ABT-263, Etoposide, and 
Thymalfasin. Four drugs were associated with the mental health condition 
Parkinson’s disease, post-traumatic stress disorder or anxiety: L-DOPA, 3,4-
Methylenedi-oxymethamphetamine, Encapone, and Tolcapone. One drug binding 
sites was specifically targeted ecstasy.  
 
  
 COMT DB0066
8 
Epinephrine active sympathomimetic 
hormone from the adrenal 
medulla 
anaphylaxis and sepsis 
Table 7: Drug binding sites were annotated for the genes in the hotspots. When genes in the 
hotspots were annotated for drug interactions, 16 drug binding sites were found for both 
commercially developed and illicit substances. 
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Discussion 
We have observed that addiction and mental health genes create eight hotspots in 
the genome. Their shared functional annotation and drug binding site annotation 
support the idea that this clustering is meaningful. This approach helps to unify the 
disparate clinical, genetic, and functional observations about addiction and mental 
health co-morbidity. Our analyses demonstrate that genes curated for their 
involvement in opiate, GABA and dopamine addictions share significant genomic 
position overlap with genes involved in the bipolar disorder, depression and 
schizophrenia. Additionally when we perform functional annotation on these gene 
sets, we find that they share core molecular processes such as cell-cell signaling, 
synaptic transmission and responses to organic substances. These genes also 
share more amorphous processes such as learning, memory and behavior. Finally 
we found that when these addiction and mental health genetic hotspots were 
annotated for their drug interactions, they identified binding sites for illicit drugs, 
cancer drugs, and neurological degenerative disorders such as Parkinson’s disease.  
 
While there has been significant identification of the clinical synergies between 
addiction and some mental health phenotypes (32, 33, 82), we show here that a 
subset of these addiction and mental health genes actually sit in genomic windows. 
These genomic windows contain four of the 51 genes that are common to all gene 
lists (Table 6); instead we found that genes sitting in genomic hotspots were often 
shared by only two of the comparisons. When mapped to the genome, these regions 
were not random with respect to genome locality. These eight hotspot regions 
contain 192 of the 1968 unique genes identified as participating in addiction and 
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mental health genetics and represent nearly 10% of genes associated with addiction 
and mental health.  
 
Functional annotation of genes residing in the windows provides a verification of the 
role that these genes play within the wider context of the genomic region they 
inhabit. It is reassuring that our analyses return functional categories emphasizing 
the shared role that neurological system regulation, cell-cell signaling, stimulus 
response and organic substance response play in the development of mental health 
and addiction disorders. These findings support the complex functional interactions 
between opiate, dopamine and GABA addictions with schizophrenic, depressive and 
bipolar mental health disorders. 
 
Previous studies have identified that drugs involved with addiction and mental health 
may have pleiotropic effects (82). It is therefore of significant interest to characterize 
the drug targets in these hotspot regions. We found that drug binding sites fall in to 
three major therapeutic categories, those related to cancers, those related to up 
regulation of immune responses and those involved in neurodegenerative disorders. 
Of particular interest was the hotspots located on chromosome 19 (ABT-263, 
Abiraterone, Minoxidil, and Sorafenib) and chromosome 22 (Acetaminophen, 
Tolcapone, Encapone, 3,4-Methylenedi-oxymethamphetamine, L-DOPA,  and 
Epinephrine).  
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The observation of increased anxiety behaviors and morphine consumption in a 
Sprague-Dawley rat model suggests that genetic variation in the epinephrine-
mediated norepinephrine signaling pathway may be a novel mechanism for affective 
behavior such as anxiety and addiction(143). In a human study of African American 
young adults, levels of urinary epinephrine were predictive of drug use a year 
later(144). The drug binding site for epinephrine is located in the chr22 hotspot gene 
COMT. Sorafenib, a hepatocellular carcinoma treatment, is mediated by cellular 
signaling mechanisms. This drug target annotation is consistent with the genomic 
functional annotation of the genes underlying addiction and mental health disorders. 
There is some evidence of genetic variant mediated drug resistance. Sorafenib can 
activate addiction switches leading to reduced drug efficacy (145). While the 
mechanisms of this are not fully elucidated, the localization of Sorafenib among 
known addiction genes could be a reason for this trigger and bears further 
investigation. 
We hypothesized that we could identify genomic sites that sat at the intersection of 
addiction to opiate, GABA and dopamine with mental health disorders identified as 
depression, schizophrenia, and bipolar disorder. We have shown that genes 
involved separately in these two disorders are co-located at eight genomic regions. 
Additionally we hypothesized that each of these regions might have drug binding 
sites that share functional annotations with the genes identified in the region. Our 
analyses have identified 16 drug binding target regions located in five of the eight 
hotspot regions which share functional or therapeutic activity with addiction and 
mental health disorder phenotypes. This finding compels us to speculate on the role 
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that functional ontology plays in the primary of counter-indicative phenotypes that 
these drugs present. 
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Specific Aim III: Addiction and Immunity 
Introduction 
Human immunological interactions with their environment have long been 
considered the substrate for natural selection(6). While this has been the 
acknowledged paradigm in evolutionary medicine, few connections have been made 
between concerning the evolutionary relationships between the complex chronic 
diseases underlying substance addiction and selection for immunity (39, 83). For 
example, addiction phenotypes in chronically substance abusing individuals bear 
striking similarities to immunological compromised individuals. This is thought to be 
because of an as yet under-characterized interplay between addiction phenotypes 
and immunity phenotypes. While the relationship has been documented between 
chronic substance addiction and degenerative immunity, the converse reaction is 
less well characterized. For example, opioids are known to effect host defenses (38) 
with heroin addicts presenting higher prevalence of infectious disease than those 
non-heroin abusers.  
Our previous observations of immune genes sharing genome locality with 
addiction genes at addiction hotspots motivated our interest in further understanding 
whether addiction alleles might arise in ethnic populations as a result of natural 
selection against infectious disease at immune loci.  Specifically, we hypothesize 
that alleles associated with addiction that lie within hotspots adjacent to immune 
functioning genes will be correlated to infectious disease response and by extension 
will have allele frequencies that are tied to global distributions of infectious disease 
prevalence, where the associations are of a sufficient duration to be the substrate for 
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natural selection. To date this has been a challenging endeavor due to the lack of 
global population sets within which to test these hypotheses.  
 
One approach to studying natural selection in humans has been to examine 
single genes in a population to directly assess selection caused by some 
environmental effect (i.e. HBB and malaria, SLC24A5 and UV exposure) (146, 147). 
An analysis conducted on a global population set has demonstrated success in 
identifying variation in allele frequencies between populations taking into account 
diet, subsistence strategy and ecoregions (148). Indeed this approach can be seen 
as a major innovation in multivariate analysis for factors affecting gene frequencies 
in human populations. No portrait of environmental selection pressures would be 
complete without the inclusion of disease status and pathogen density. The interplay 
of nutrition, location, and exposure to pathogens are compelling external forces that 
impact individual survival.  
 
By examining correlations between environmental and disease conditions with allele 
frequencies, we will be able to search for allele frequencies consistent with 
signatures of selection on multi-locus traits(148).  This method is useful in identifying 
adaptations (whether tolerance or resistance focused) for complex infectious 
diseases. Asian populations provide an opportunity to examine how environmental 
effects affect complex traits because they exhibit a variety of subsistence strategies, 
population histories and exposures to infectious disease. They also live in a variety 
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of ecological regions, nutritional contexts and latitudes. These various conditions 
make them a living laboratory for studies in natural selection.  
 
Specific Aim III: Determine whether of infectious disease burden plays a role 
as an evolutionary driver of addiction genetics. 
 
I hypothesize that environmental factors such as geographical location, relative 
pathogen burden and infection rates will identify allele frequency differences in 
ethnic population for immune and addiction gene hotspots. We further hypothesize 
that these hotspots are consistent with natural selection within human populations 
living predominantly in tropical environments.  This finding would establish a critical 
link between the agent of natural selection, the genetic process and a complex 
disease that lies within the close proximity to an allele under selection. 
 
Methods 
Identification of Immune and addiction gene clusters 
To test whether there are correlative relationships between diet, ecoregions, disease 
and population allele frequencies, we use genes contained in addiction and immune 
gene step curated by NCBI. Immune associated genes were identified from NCBI 
gene lists using search terms, ‘adaptive immunity,’ ‘innate immunity,’ ‘autoimmunity,’ 
and ‘Th1/Th2.’ These terms were added to 587 genes previously identified as being 
involved in opiate, dopamine, and GABA reception addiction. These genes were 
then projected onto the genome to identify cluster regions of genetic importance for 
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immunity and addiction. Clusters were defined as regions of the genome with more 
than 25 genes within a 2.5Mb linear genomic window. 
 
Annotation of Genes in the Addiction and Immunity Windows 
To determine the functional role that these NCBI Genes for addiction and immunity 
as well as candidate genes hotspots play, we performed functional annotation for 
these three hotspot regions. Genes located within hotspots were considered in two 
ways in statistical enrichments: all genes in the hotspot window, and only those 
previously linked to addiction.  All genes in the hotspots were annotated using 
DAVID’s Bioinformatics Resources Tool software (101, 102) for biological process, 
molecular function, and KEGG pathways (46, 49). Functional enrichments were 
quantified using pV < 0.05 and Benjamini score analysis cutoffs of 0.01 (103). KEGG 
pathways were colored using a MATLAB code to differentiate between genes 
belonging to different hotspots.  
 
Populations Studied and Determination of Environmental Context 
 
In order to understand how populations vary at these key addiction and immunity 
clusters, we surveyed human polymorphism data from the 1054 individuals 
comprising 51 populations of the Human Genome Diversity Panel (HGDP), and the 
1078 individuals comprising the 11 sample populations of the HapMap project 
dataset. The set of polymorphism shared amongst these populations was identified 
and cross population comparisons were made on allele frequencies. Figure 16 
shows the sample populations.   
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To determine how populations fit into ecological regions, a map with population 
sampling locations was cross-referenced to global Bailey’s ecoregions maps (149). 
This map characterizes the environmental conditions under which study populations 
live.  Figure 16 also makes a comparison between those populations living in tropical 
environments as identified by the Bailey’s ecoregion map for a global population set. 
We used sampling locations as the determinant for the locality of the population. For 
this analysis, the Human Genome Diversity Panel populations were more 
appropriate to differentiate between those populations Population sample locations 
were cross-referenced with the World Health Organizations’ public health indicators 
(available online at: http://apps.who.int/gho/data/?theme=main).  Disease prevalence 
and pathogen load data for various infectious diseases including: malaria 
(Plasmodium vivax and P. falciparum), Cholera (Vibrio cholera), Polio (Poliovirus 
spp.), Schistosomiasis (Schistosoma japonicum and S. mansoni) and Yellow Fever 
(Yellow fever virus) were obtained from World Health Organization datasets to 
characterize the epidemiological environments within which population samples live 
along with additional health indicators which might determine the role that these 
pathogens might play in determining the in allele frequency variation.  
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 Populations SNPs typed N. of 
Individuals 
# of Tropical 
populations 
HapMap Populations 11  ~10 million through Phase 
III 
1078 1 
Human Genome Diversity 
Panel 
51 650,000 1054 15 
 Figure 15: Ethnic populations surveyed for immunity and addiction crosstalk from the HapMap and Human 
Genome Diversity Project.  The HapMap populations (populations described in Table 1) and the HGDP populations: 
HGDP Africans (green)- Moazibite,  Mandenka, Yoruba, Biaka, Mbuti, San, NE Bantu, and SAf Bantu. HGDP Asians 
(purple); N. Asia: Oroquen, Daur, N. Han, Hezhen, Japanese, Uygur, Xibo); C. China: Han, Yi, She, Tu; S.E. Asia: Naxi, 
Lahu, Dai, Miao, Cambodian), S. Asian (burgundy): HGDP Europeans (blue): Adygei, Basque, French, North Italian, 
Orcadian, Russian, Sardinian, and Tuscan ;  and HGDP Oceanians (orange): Melanesia, Papua  
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Geographical mapping of correlated variants 
To assess the effect of disease on the Acute Inflammatory Response Pathway, we 
surveyed 10 genes associated with this process (AHSG, APCS, C2, CEBPB, 
CFHR1, KRT1, LBP, MBL2, ORM1, and SIGIRR) were all part of our immune NCBI 
Gene lists. This subset of genes was identified using the Molecular Signatures 
database housed in the Gene Sets Enrichment Analysis database (available online 
at: http://www.broadinstitute.org/gsea/index.jsp). Acute Inflammatory Response 
functions in short lived antigenic challenge as is demonstrated from infectious 
diseases such as Hepatitis B and Hepatitis C. All single nucleotide polymorphisms 
(SNPs) typed in the 10 genes were assessed for their allele frequencies following 
the Hancock methodology (148). This refers specifically to SNPs typed in the HGDP 
populations using the Illumina 650Y platform. SNPs were filtered to exclude those 
that had minor allele frequencies that fell above 0.90 and below 0.10.  These sites 
were then sorted by geographical region of sample origin into major sub continental 
regions (Sub-Saharan Africa, Central Asia, Northern Asia, Central China, Southern 
Asia, and Oceania).   
 
To test whether there is a correlation between Hepatitis B, acute inflammatory 
response and geography, a Pearson correlation analysis was performed between 
the variables of mean acute inflammatory response frequency and disease (150). 
Candidate and neutral SNP sets were combined and a Spearman Rank Correlation 
was performed to determine whether candidate SNPs were found to be statistical 
outliers. 
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Results 
 
Addiction and Immunity Hotspots 
Our analyses identified three hotspots containing genes from both addiction and 
immunity NCBI Gene lists. We note that these three genomic hotspots were 
identified despite the lack of intersection of gene sets between the addiction and 
immunity. Addiction and immunity hotspots were located on chromosomes 11, 
17and 19. Table 8 identifies the genes in this study with NCBI identified genes 
bolded and those gene names were color coded to represent the category of gene 
list with which these genes were initially identified. Hotspots all shared genes from 
immunity and addiction gene sets.  The chromosome 11 hotspot contained 10 genes 
from autoimmune, cocaine, alcohol and innate immunity lists along with seven genes 
previously unidentified as participating in addiction and immunity phenotypes.  The 
chromosome 17 hotspot contains 11 genes from innate immunity, alcohol, morphine, 
and Th1 along with 44 previously unassociated genes. And finally the chromosome 
19 hotspot locus contains 18 genes from alcohol, GHB, autoimmune, innate 
immunity and Th2. 
 
Addiction and Immunity Hotspot Annotation 
 
We used David’s Functional Annotation web tool to annotate the genes that were 
identified in each hotspot and to determine the role that each hotspot played in 
addiction and immunity disorders. The chromosome 19 hotspot is located between 
47.8 and 49 Mb of the Hg18 build of the human genome.  
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Chr Location Genes in Window 
11 46,406,640-
47,606,115 
CREB3L1, DGKZ, MDK, CHRM4, AMBRA1, HARBI1, 
ATG13, ARHGAP1, ZNF408, SNORD67, F2 (autoimmune and 
innate), LRP4, C11orf49, CKAPS, ARFGAP2, 
ACP2(Autoimmune and alcohol), NR1H3 
17 39,393,369-
41,277,468 
KRT16, KRT42P, EIF1, GAST, HAP1, JUP, LEPREL4, 
KLHL10, FKBP10, ACLY, TTC25, CNP, DNAJC7, NKIRAS2, 
ZNF385C, DHX58, KAT2A, HSPB9, RAB5C, HCRT, GHDC, 
STAT5B, STAT5A(TH2 and Autoimmune), STAT3, PTRF, 
ATP6V0A1, NAGLU, HSD17B1, MLX, COASY, PSMC3IP, 
FAM134C, TUBG1, TUBG2, CCR10, PLEKHH3, CNTNAP1, 
EZH1, RAMP2, VPS25, WNK4, CNTDN1, BECN1, PSME3, 
AOC3, AOC2, G6PC, AARSD1, PTGES3L, RPL27, IF135, 
RUNDC1, VAT1, RND2, BRCA1 
19 47,870,466-
49,085,208 
SULT2A1, BSPH1, ELSPBP1, CABP5, PLA2G4C, LIG1, 
CARD8, ZNF114, CCDC114, TMEM143, EMP3, SYGR4, 
KDELR1, GRIN2D(alcohol and cocaine), GRWD1, KCNJ14, 
CYTH2, SULT2B, FAM83E, SPACA4, RPL18, SPHK2, DBP, 
CA11, NTN5, FUT2, MAMSTR, RASIP1, IZUMO1, FGF21 
PLEKHA4, PPP1R15A, TULP2, BCAT2, HSD17B14, DHDH, 
BAX, FTL, GYS1, RUVBL2, LHB, CGB, CGB2,  CGB1, 
CGB5, CGB8, CGB7, NTF4, KCNA7, SNRNP70, LIN7B , 
PPFIA3, HRC, TRPM4,  SLC6A16, CD37, TEAD2, DKKL1, 
CCDC155, ALD16A1, SLC17A7, PIH1D1, FLT3LG (Th1 and 
Adaptive), RPL13A, SNORD32A, RPS11, FCGRT, RCN3, 
NOSIP, PRRG2, RRAS, PRR12, SCAF1, IRF3 
 
Table 8: Genes identified at the intersection of Addiction and Immunity. Three 
hotspot regions were identified located on chromosome 17, 11, and 19. Each 
hotspot had genes identified through multiple addiction and immunity gene lists. 
 
 
. 
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 Biological Processes Molecular function KEGG Pathways 
CHR Process P Function P Pathways 
17 JAK-STAT Cascade 5.4-5 Phosphate binding 0.01 -Acute myeloid leukemia 
-Adipocytokine signaling pathway 
Growth hormone receptor 
signaling pathway 
2.5-4 GTPase activity 3.6-3 
Response to growth hormone 6.6-3 Steroid hormone receptor binding 5.8-3 
Homeostatic process 0.01 Ion binding 0.04 
eating behavior 0.02   
11 catalytic activity 
 
0.01 
 
nucleotide regulator activity 0.01 -Regulation of actin cytoskeleton 
-Neuroactive ligand-receptor 
interaction 
-Cholinergic synapse 
-Hepatitis B  
-Complement and coagulation 
cascades 
-Peroxisome 
-Hypertrophic cardiomyopathy 
-Nucleotide excision repair 
-Dilated cardiomyopathy 
-Alcoholism 
protein import 
 
0.02 enzyme activator activity 3.0-3 
regulation of cellular protein 
metabolism 
0.04   
Negative regulation of 
endocytosis 
0.02   
Regulation of phosphorylation 0.04   
19  fertilization 3.4-3 Hormone activity 6.6-4 -Ribosome 
 
  
Neurotransmitter transport 4.0-3   
Cell-cell signaling 7.7-3   
Single fertilization 0.02   
Table 9: Functional Annotation of Addiction and Immunity Hotspot Crosstalk Regions.  Genes identified in each 
hotspot were annotated from biological process, molecular function and pathway participation.  Annotation was 
undertaken using DAVID functional annotation with a P value cutoff of 0.05.  
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Figure 16:  Five SNPs underlying the Chr 11 hotspot vary between high 
tropical versus low tropical living HGDP populations. Allele frequencies were 
plotted in the tropical living climates (blue) versus those living in temperate climates 
(red). The inset shows the hotspot locations.  
 
Annotation of Tropical identified SNPs 
We further annotated the top five polymorphisms that showed allele frequency 
differences between populations that lived in temperate environments and those 
living in tropical environments as illustrated in Figure 2. These five SNPs were 
identified in the HGDP populations: rs11818969, rs17790342, rs12417519, 
rs752849, and rs901746. Annotation of these five SNPS varying showed that they 
exhibit addiction, mental health and immune function. These SNPs are further 
characterized in Table 7. Additionally we typed these five polymorphisms in the 11 
HapMap populations to understand whether these populations showed similar 
patterns to the HGDP population datasets. Our analyses confirm that they HapMap 
 and HGDP populations show allelic congruence at these five sights, suggesting this 
pattern is a true representation of what is happening in human populations. 
Table 10: Top five SNPs have shared
in HapMap populations as in HGDP populations. 
location type and gene. We then typed these genes in the HapMap populations and 
found congruence in the tropical populations of the HapMap and those of the 
 
The rs11818969 polymorp
gene (AMBRA1) is intimately involved in the d
(151). It has been shown to b
autophagy, cell growth and cell death of crucial importance
(152). In particular, the rs118189
Schizophrenia associated polymorphism 
polymorphism has extended this work to find that it specifically a
related behavioral and neural traits 
than four times more prevalent in African populations than in Europeans and more 
than 15 times more prevalent than in East Asian populations of the HapMap. In an 
African American HapMap sample collected in the southwestern United States 
(ASW) the frequency was found to
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 patterns of allele frequency differences 
SNPs are identified with their 
hism found in the autophagy/beclin-1 regulator 1
evelopment of the nervous system 
e a component of a complex network between 
 to neural development 
69 polymorphisms have been identified as 
(153). A follow up study of this 
lters impulsivit
(154). We note that the AMBRA2 gene is more 
 be 0.592 
 
 
HGDP. 
 
y-
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There were three polymorphisms, rs17790342, rs12417519, and rs752849, which 
are located in the Chromosome 11 open reading frame 49 (C11orf49). While open 
reading frame regions in the genome are not well characterized, these particular 
SNPs have been identified as participating in the liver interactome (155). The liver is 
the site of metabolism of xenobiotics so these SNPs may have metabolic function. 
 
Finally the rs901746 polymorphism is located in the Damage-Specific DNA Binding 
Protein 2 (DDB2). DDB2 is involved in the repair of UV damage to DNA. The DDB2 
gene participates in a complex that mediates the ubiquitylation of histones H3 and 
H4, which facilitates the cellular response to DNA damage. Additionally, the DDB2 
genes has been implicated in lung cancer susceptibility (156), and most importantly 
in the destabilized the Hepatitis B viral protein X (157). This destabilization of the 
viral protein X is thought to be a key component in the prevention of viral particle 
proliferation.  
 
We used GWAS3D software to look for local and long range interactions identified 
from genome wide association studies, regulatory variation. In particular it is good 
for characterizing noncoding phenotypically associated variants that underlie the 
molecular mechanisms of complex traits. Our analysis identified three long range 
interactions with AMBRA1 (see Figure 17). The first occurs between the AMBRA1 
gene, and 2 genes located in a chromosome 8 interaction window: ZNF705D is a 
zinc finger protein that is thought to be involved in transcriptional regulation, while 
FAM66D, is a human specific gene that is known to interact with 
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Tetrachlorodibenzodioxin. According to the Comparative Toxicogenomics Database, 
Tetrachlorodibenzodioxin has more than 1000 documented interactions with AHR 
(N=3255 Interactions) and CYP1A19 (N=1795 Interactions) and is also used as a 
treatment for drug-induced liver damage. 
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Table 11:  GWAS3D analysis of the tropical segregating polymorphisms showed interacting SNPs, transcriptions 
factors and ACP2, a gene involved in de-phosphorylation. We characterized the set of SNPs that were frequency 
divergent in tropical and non-tropical living populations. The set had interacting SNPs that were locally located, often in 
the same gene with the exception of rs901746 which interacted with rs2167079 at ACP2, an adjacent gene. Three of the 
interacting SNPs sat within transcription factors, with the ACP2 gene SNP (rs2167079) sat at the intersection of 62 
different transcription factors.
dbSNP ID GENE SNP Functional 
Annotation 
Interacting 
dbSNP ID  
CHR:location GENE Location Transcription 
Factors? 
rs11819869 AMBRA1 Schizophrenia 
associated  
rs7130141 11:46499874 AMBRA1 Intronic Yes- EBF1 
rs17790342 C11orf49 Liver interactome rs12576831 11:47082255 C11orf49 Intronic No 
rs12417519 C11orf49 Liver interactome rs11601798 11:47158392 C11orf49 Intronic No 
rs752849 C11orf49 Liver Interactiome rs7940473 11:47182353 C11orf49 Intronic Yes- CTCF 
rs901746 DDB2 Inhibition of Hepatitis B 
Protein X 
rs2167079 11:47270255 ACP2 Coding Yes- 62 TFs 
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Figure 17: GWAS3D analysis of the five single nucleotide polymorphisms 
found to differ in tropical versus non-tropical living populations show that 
SNPs have local and long range interactions. AMBRA1 showed 2 long range 
interactions on chromosomes 3 and 8 along with a local interaction on 
chromosome 11. The ACP2 gene (rs2167079), an interacting partner of rs901746, 
had three interactions: at Xq26.1, 1q21.1, and 7p15.2. 
90 
 
The second region with AMBRA1 interactions is a 10Kb chr3 interaction region 
(chr3:136520001-136530000) that lies just upstream of the SLC35G2 gene. While 
this gene is not well annotated, there are 13 ENCODE-identified different 
transcription factors found bundled together (FOS, KAP1, JUN, MEF2, NFIC, BATF, 
ATF2, USF1, USF2, CTCF, GATA3, and RUNX3). The third regional interaction is a 
local one located between the AMBRA1 gene and a local chr11 region 
(chr11:46180001-46190000). There is one polymorphism identified as rs7128538 
which has been associated with Systemic Sclerosis (158). 
 
Two regions were shown to have strong enhancer signatures:  chr11:46046791-
46539727 and chr11:46446962-46516078. These signatures are generated from the 
ENCODE analysis of H3K4me1, H3K27ac, P300, and DHS. These enhancers 
represent epigenetic enhancers of on genomic sequences. Finally there was one 
identified Conservation Region of GERP++ Elements located at chr11:46499803-
46500030. GERP++ Elements are constrained elements in multiple alignments and 
are estimates potential functional constraint. These are summarized in Table 11. 
 
Acute Inflammatory Response and Hepatitis B 
Following up on this observation that rs901746 is a polymorphism involved in 
Hepatitis B prevention, and our hypothesis that infectious disease might be the 
driving force shaping allele frequencies at adjacent addiction and mental health 
sites, we wanted to identify whether we could identify if there was a correlation 
between Hepatitis B infection prevalence in a global set of human populations and 
these populations. When we studied 10 genes associated with acute inflammation in 
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HGDP Africans (Africa- Mandenka, Yoruba, Biaka, Mbuti, San, NE Bantu, SAf 
Bantu), Asians (N. Asia: Oroquen, Daur, N Han, Hezhen, Japanese, Uygur, Xibo); C. 
China: Han, Yi, She, Tu; S. Asia: Naxi, Lahu, Dai, Miao, Cambodian) and Oceanians 
(Oceania: Melanesia, Papua),  we found that there was a trend towards significance 
(pV= 0.08). Alleles were then correlated to a map of hepatitis B prevalence 
described from sentinel surveillance conducted in 2004 (159). 
Mean allele frequencies were calculated within an ethnic group sample and 
then across a geographical region (Figure 18) . These candidate regions were 
compared to neutral SNPs identified using HOMINID coordinates representing 71 
regions of the human genome that are far from genes/motifs and are thought to be 
consistent with neutral evolutionary processes.  On the x axis – the mean minor 
allele frequency (MAF) for African populations was 0.3418, while the mean pan 
Asian MAF mean was 0.3781. This was significantly different (p = 0.00436). When 
Asian populations were grouped regionally, Central Chinese sample locations (Han, 
Yi, She, and Tu) had a MAF mean almost identical to African populations (0.3428), 
and the central Chinese population differed significantly from N. Asia and S. Asia 
regional means (p=0.0045 and p=0.0022, respectively) using  the Student’s T-test 
statistic to determine significance.  
To test whether there is a correlation between Hepatitis B, acute inflammatory 
response and geography, we performed a Pearson correlation analysis between the 
variables of mean acute inflammatory response frequency and disease (150). This 
result is consistent with the central Chinese region being a nexus of Hepatitis B 
transmission. The pattern observed in genes of the acute inflammatory response 
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pathway is consistent with the observation that acute inflammation is an integral part 
of the Hepatitis B infection process (155). When HGDP sampling locations are 
overlaid with Hepatitis B prevalence maps, there is trend towards congruence 
between high Hepatitis B prevalence and low MAF frequencies (159).  
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Fig 18: Neutral SNPs in global human populations and the Acute Inflammatory response gene set surveyed in a 
diverse set of African and East Asian populations. Neutral SNPs only show significant differences between Africans 
and non-African populations.  A Pearson correlation of Hepatitis B prevalence and mean acute inflammatory response 
allele frequency shows a trend toward correlation (p=0.08).  
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Discussion 
Our findings show that genes involved in opiate, dopamine and GABA addiction do 
form three genomic hotspot regions in conjunction with immunity regulating genes 
within the human genome. These positions are located on three separate 
chromosomes: chr 9, chr 11, and chr19. Functional annotation of these joint 
addiction and immunity hotspot regions confirmed that the genes previously 
identified in either addiction or immune surveys share broad functional classifications 
with those candidate genes that are their hotspot neighbors. Finally when we survey 
genetic polymorphisms that underlie these three genomic regions in a global 
distribution of human populations we find that when populations are grouped by their 
locality in tropical ecological zones, we identified polymorphisms that significantly 
differ at the chromosome 11 hotspot region. Further annotation of these climate and 
frequency divergent polymorphisms showed that they have been identified as 
playing key roles in liver interactome function, schizophrenia and Hepatitis B 
infection. A follow up analysis of the relationship between Hepatitis B and the acute 
inflammation process points to a correlation between Hepatitis B and acute 
inflammation pathways in African and Asian populations living in those areas of the 
continent that have high hepatitis burden. Taken together, our results point to a 
functional trifecta existing between immunity, addiction and mental health related 
SNPs at the chromosome 11 locus.  We can infer that hepatitis B is at least a 
contributing factor in the addiction and mental health allele frequencies that are seen 
in tropical living populations.  
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 When these addiction and immunity genomic hotspots were functionally 
annotated using the David’s functional annotation web tool (101, 102, 160, 161), we 
found that while hotspots were not well annotated with common computational tools, 
the genes underlying these regions represent candidates for both mental health ( 
and infectious disease genes. Interestingly, alcoholism was one of the KEGG 
pathways identified as participating in the metabolic dynamics of these genomic 
regions. This gives additional support to our conjecture that the SNPs for C11orf49 
may indeed play a role in the liver interactome in a manner that potentially creates 
susceptibility to alcoholic substances. 
We considered the relationship between tropical-living populations, as a 
climatological surrogate for multiple pathogen loads. These analyses determined 
that those populations living in highly tropical environments showed the highest 
polymorphism frequency differences to their temperate climate-living population 
comparisons. This was true when populations were considered without respect to 
ethnic origin, confirming that human population locality and more specifically 
proximity to pathogens was sufficient to explain the observed allele frequency 
differences. This finding further supports the idea that local climate and specifically 
potential disease burden appear to play a significant role in shaping both 
immunological but also co-located non-immunological phenotypes.  
Previous studies examining the role of climate – either as a surrogate for 
pathogen load (162) or as a function of climate change (163) have shown that local 
climate affects the availability of the pathogen substrates that are thought to drive 
natural selection in human populations. It is therefore not surprising that selection for 
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immune fitness can lead to hitchhiking of addiction associated SNPs. The proximity 
of these polymorphisms indicates that their evolutionary histories are intertwined. 
This concept now gives us a fertile ground on which to build further analyses 
between the addiction alleles and immune-regulatory elements under infectious 
disease based selection. Furthermore, there is evidence that opioid peptides may 
have first arisen as modulators of cellular immune function- where morphine down 
regulates immune processes in addiction, an action/function that it appears to 
normally perform (39). This strengthens our argument that these putatively adaptive 
features that increased human fitness in disease rich environments may now be 
causing secondary effects when the immune pressure is removed, or when 
xenobiotics such as the addictive substances we study here are given in non-
homeostatic doses.  
Our assessments of GWAS3D interacting polymorphisms showed that the 
five polymorphisms identified have both local and long distance interactions. These 
interactions include rs2167079, a coding SNP that sits in at least 62 transcription 
factors. These analyses demonstrate that addiction genes do indeed form genomic 
hotspots with immune genes, that these immune hotspots share functional 
cohesiveness, and that when SNPs at these addiction and immunity hotspots were 
compared between HGDP populations living in tropical versus temperate climates, 
they identified SNPs associated with hepatitis B, the liver interactome, and 
schizophrenia. A follow on analysis of a subset of immune genes involved in the 
acute inflammatory response show congruence with reported hepatitis B endemicity 
geographic distributions in central Asia and sub Saharan Africa.  This analysis begs 
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follow up in understanding how pervasive this phenomenon is in complex disorders 
and their associated immune responses.  
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Conclusions 
Summary of Findings 
Addiction disorders represent a major economic and health cost to human 
populations (51). Addiction is loosely defined as a chronic relapsing spectrum 
disorder characterized by loss of control over substance taking (52-54). It is a 
behavior-based phenomenon representing a diverse array of psychological, 
biological, and genetic attributes and environmental and cultural factors (55-57).  As 
with addiction, neurological disorders such as depression, bipolar disorder, and 
schizophrenia represent a significant strain on health and judicial entities. Both 
addiction and mental health disorder classes have long been identified as co-morbid 
conditions (124). While we can make clear inferences about the role that genes play 
in Mendelian genetic disorders, characterizing the genetic underpinnings of complex 
disease has been significantly more challenging. The intersection of two complex 
diseases such as addiction and mental provides an additional level of genetic 
complexity. Both Substance addiction and mental health are behavior-based 
phenomenon representing a diverse array of psychological, biological, and genetic 
attributes and environmental and cultural factors (32, 33, 55-57).  Schizophrenia is a 
mental illness that affects 1% of the global human population(132). It is identified as 
a disorder that disrupts brain neural networks and is characterized by hallucinations, 
delusions, lack of willpower, and cognitive deficits (164). Genealogy studies have 
shown that there is a strong genetic component to schizophrenia with genetic 
components accounting for as much as 80% of the risk variance (165). Linkage 
studies and candidate gene approaches have identified over 1000 candidate genes 
associated with schizophrenia. By examining correlations between environmental, 
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addiction, and disease conditions with allele frequencies, I searched for allele 
frequencies consistent with signatures of selection on multi-locus traits.  This method 
is useful in identifying adaptations (whether tolerance or resistance focused) for 
complex infectious diseases. Tropical populations provide an opportunity to examine 
how environmental effects affect complex traits because they exhibit a variety of 
subsistence strategies, population histories and exposures to infectious disease. 
 
A list of biologically relevant genes for addiction was gathered from literature curated 
sources. Figure 3 shows the flowchart employed to identify biologically relevant 
addiction genes and the resulting number of genes in each addiction gene set. 
Three classes of addiction genes were obtained using the NCBI gene search: 
dopamine addiction genes (N=108), opiate addiction, (N=246) and GABA addiction 
genes (N= 433). The search word chains consisted of ‘metabolism’ (N=398 genes) 
or ‘addiction’ (N=461) followed by the names of three addictive substances: 
dopamine, opiates and GABA receptor. The respective heat maps in Figure 3 
illustrate the intersections within the search terms for both metabolism and addiction 
gene lists. Additionally, we compared our gene list to the one reported by Li, Mao 
and Wei (1),  containing 387 genes involved in four addiction disorders.  This 
comparison is shown using a Venn diagram with the bulk of genes (N=311) not 
identified in our analyses belonging to nicotine addiction, an addiction disorder we 
do not address here.  The rest was added to our gene list. A set of addiction genes 
(N=587), compiled from the union of all search terms, was thus determined.   
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We hypothesized that genes involved in the characterized opiate, dopamine and 
GABA addiction disorders will form genomic regions of with functional specificity. 
These regions should exist above and beyond that small subset of genes that are 
shared between these gene lists. Our analyses demonstrate that genes associated 
with dopamine, opiate and GABA addictions cluster into seven regions of the 
genome that have a significant or near significant overabundance of addiction genes 
based on a hypergeometric test (Table 2). These seven hotspots were split between 
GABA specific (4q23, 6p22.2, 6p22.1) and mixed addiction hotspots, containing all 
genes, (10p15.1, 11q13.2-3, 16q22.1, and 19q13.33). 
 
Functional annotation was undertaken for the list of addiction genes, the GABA, 
opiate, and dopamine addiction classes, and their pairwise intersections. These 
genes when functionally annotated both with and independent of their interspersed 
neighbor genes shared functions. This finding supports the idea that these NCBI-
curated hotspot genes are truly identifying regions with functional genomic 
signatures for addiction. Functional annotation shows a wide range of biological 
processes dominated by cell-cell signaling.  Dopamine and opiate addiction gene 
lists shared many more molecular functions with each other than they did with the 
GABA addiction gene set. The genes common to the three types of addiction under 
consideration included those with ligand-gated ion channel activity, neurotransmitter 
binding, and amine binding activities. The biological processes enriched included 
response to organic substances, synaptic transmission processes, and response to 
endogenous stimulus process. This approach has identified additional candidate 
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genes such as those in the SLC17A family, which code a sodium/phosphate co-
transporter in the intestinal mucosa. The protein plays an important role in the 
absorption of phosphate from the intestine and its possible role in addiction is yet to 
be determined. 
 
We examined the hotspot associated polymorphisms identified in 11 HAPMAP 
sample populations with distinct geographical occupation: East Asian ancestry 
[Japanese-JPT, Chinese (collected in Beijing)-CHB, Chinese (collected in Denver)-
CHD], African ancestry populations [Yoruba-YRI, Masaai-MKK, Luhya-LWK, and 
African Americans-ASW], European ancestry populations [Europeans of Northern 
and Western Ancestry-CEU and Toscana- TSI], a South Asian ancestry population 
[Guajarati in Houston-GIH]; and an admixed American population [Mexicans in Los 
Angeles-MEX] (104-106).  To exclude the possibility of confounding effects of 
population-specific demography and to set up an empirically derived neutral 
estimate of allelic variation, we analyzed 20 concatenated autosomal loci across the 
human genome identified as neutrally evolving (107). It was assumed that the 
polymorphism variation undergoing selection will have non-neutral allele frequency 
patterns. When we considered genetic polymorphisms in 11 HapMap populations 
that span three major ethnic regional populations (East Asian, European, and 
African), we identified polymorphisms (as shown in Figure 9 that varied between 
East Asians and Africans/Europeans populations (rs6906576, rs6924948, 
rs7740793, rs9348699, rs933199).  
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We followed these frequency-based analyses of hotspots with analysis uncovering 
linkage to distant sites. For this purpose we used the web platform GWAS3D 
developed recently by Jun Li M et al. (109). The platform identifies genetic variants 
affecting regulatory pathways and underlying disease/trait associations by 
integrating chromatin state, functional genomics, sequence motif, and conservation 
information given a variant list. In the addiction case under study, we examined the 
distant regulatory landscape through linkage of the significant SNPs identified at 
hotspots in cross population comparisons. Figure 11 shows the significant common 
variants between Africans and Europeans projected onto the Yoruba population. In 
the outer ring, polymorphisms or genomic regions are identified. The second ring 
identifies the genes or chromosomal regions these polymorphisms sit in and finally 
the red lines indicate the strength of local or long range interactions. Thus, with the 
use of emerging bioinformatics web platforms, deciphering addiction hotspots on the 
human genome show potential for further discovery of DNA motifs distant to the 
hotspots. 
 
These addiction findings made us question whether our computational approach 
could be used to identify those genes that are sitting at the intersection of multiple 
complex disorders.  A number of studies have identified the clinical intersection of 
mental health and substance addiction traits (125, 126). This has been shown in a 
diverse variety of mental health conditions such as depression (127, 128), bipolar 
disorder (129-131), and schizophrenia (132-137). To date, the crosstalk of addiction 
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and mental health genetic contributors has not been fully understood based on 
association studies (68, 138) and functional genomics (41, 42). 
 
The bipolar disorder gene list comprised 626 genes, depression comprised 357 
genes, schizophrenia comprised 1121 genes and Addiction comprised 587 genes 
garnered from opiate, GABA and dopamine addictions. When considered together 
this genes list represented 1968 genes encoding putative addiction and mental 
health targets. Figure 12 is a Venn diagram that shows the overlap in genes from 
these four lists. Interestingly, there were 51 genes that were shared between all 
gene lists but only four of these shared genes were represented in the eight 
hotspots. These are indicated in red in Table 6. This overlap gene set contained the 
DRD, HTR and SLC6A gene families as well as a host of immune function genes 
including: ICAM1, IFNG, IGF1, IL1B, IL1RN, and TNF. Of this combined set of 
addiction and mental health genes, 192 genes fell into cluster regions within the 
genome.  Our analyses identified these eight genomic regions (with significant 
numbers of genes involved in the dual disorders of addiction and mental health.  
 
We performed a functional annotation on the complete list of NCBI identified genes 
in order to determine the major functional roles for addiction and mental health 
genes. Functional annotation of the combined set of depression, schizophrenia, 
bipolar and addiction genes found functional commonalities.  These functions are 
characterized in Figure 14. 
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Drug target annotation was performed to determine the role that pharmacological 
products interacted to binding sites within these hotspots.  When the hotspot regions 
were annotated for drug interactions 16 drugs were found to have binding sites with 
shared function. This function revolves around neurological function, response 
organic substances and cell-cell signaling. Addiction and depression overlapped in 
three functional regulatory roles: cellular localization, cyclic nucleotide biosynthesis 
and metabolism. While not all hotspots had drug binding sites located within their 
domains, five of the hotspots did. When we identified drugs that identified these five 
hotspots, we found some thematic division in the types of drug binding site targets. 
Five drug binding sites are associated with cancer therapies: Sorafenib, Abiraterone, 
ABT-263, Etoposide, and Thymalfasin. Interestingly, a survey of the literature 
regarding these drug’s effects showed that they were involved in secondary 
addiction and mood disorder phenotypes. Four drugs were associated with the 
mental health condition Parkinson’s disease, post-traumatic stress disorder or 
anxiety: L-DOPA, Encapone, Tolcapone, 3,4-Methylenedi-oxymethamphetamine. 
One drug binding sites were specifically directed at an illicit drug, ecstasy. These 
findings are summarized in Table 7. 
 
 We wanted to follow up our early observations that addiction hotspots genes at two 
hotspots the 6p21.1 and 4q23 were interspersed with immune function genes, and 
that polymorphisms at these hotspots showed allele frequency differences in the 
Yoruba population, a sub-Saharan tropical living African population. We 
hypothesized that environmental factors such as geographical location, relative 
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pathogen burden and infection rates will identify allele frequency differences in for 
immune and addiction gene hotspots between populations that are consistent with 
natural selection within human populations living predominantly in tropical 
environments.  
 
To test whether there are correlative relationships between ecoregions, disease and 
population allele frequencies, we use genes contained in addiction and immunity 
curated by NCBI. Immune associated genes were identified from NCBI gene lists 
using search terms, ‘adaptive immunity,’ ‘innate immunity,’ ‘autoimmunity,’ and 
‘Th1/Th2.’ These terms were added to 587 genes previously identified as being 
involved in opiate, dopamine, and GABA reception addiction (submitted in Jackson 
et al). These genes were then projected onto the genome to identify cluster regions 
of genetic importance for immunity and addiction. Clusters were defined as regions 
of the genome with more than 15 genes within a 1.5Mb linear genomic window. 
  
When addiction and immunity gene lists were combined, we found that they created 
three hotspots located on chromosomes 11,17, and 19.  In order to understand how 
populations vary at these key addiction and immunity clusters, we surveyed human 
polymorphism data from the 1054 individuals comprising 51 populations of the 
Human Genome Diversity Panel (HGDP), 1148 individuals comprising the 11 
sample populations of the HapMap Project and the 1092 individuals representing the 
1000 Genomes dataset. The set of polymorphism shared amongst these datasets 
was identified and cross population comparisons were made on allele frequencies. 
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To determine how populations fit into ecological regions, a map with population 
sampling locations was cross-referenced to global Bailey’s ecoregions maps(149). 
This map characterizes the environmental conditions under which study populations 
live.  We grouped populations into groups of tropical environment, moderate 
environment and non-tropical environment. This sorting process split African, Asian 
and American populations, thereby ensuring that the effect that we saw was not the 
result of ancestry but instead was eco-climate related.  Our analyses demonstrate 
that when we grouped a global set of 51 human populations into tropical versus non-
tropical living groups (the distal ends of our sorting spectrum), we found significant 
differences in allele frequencies at the hotspot located on chromosome 11 for 5 
polymorphisms (Table 10). Finally we used GWAS3D to identify local and long range 
interactions between our 5 significant SNPs and their cis and trans-chromosomal 
partners. 
 
These analyses have demonstrated that NCBI identified addiction genes form 
hotspots in the genome. These genomic hotspots for opiate, dopamine and GABA 
addiction share functional cohesiveness. Analyses of the SNPs typed in HapMap 
populations demonstrated that this approach can identify genomic variants of 
interest within these hotspot regions.  We then extended our analyses to the 
intersection of addiction with three mental health conditions: schizophrenia, 
depression and bipolar disorder. Each of these mental health conditions has a 
strong genetic basis and we identified 7 hotspot regions sitting in the intersection of 
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addiction and mental health. We characterized the 16 drug binding sites in five of the 
seven hotspots which recapitulated the functional intersections of addiction and 
mental health, while also indicating that again, infectious disease therapies had 
binding sites within our regions.  Finally we directly studied addiction and immunity 
genes sets to identify three genomic hotspots. These genomic hotspot again shared 
functional cohesiveness and when typed in the HGDP populations, we discovered 
that five polymorphisms had statistically different allele frequencies in tropical living 
versus non tropical living populations. These variants point to hepatitis B as a 
potential selective agent. Following this line of inquiry, we studied genes involved in 
acute inflammatory response, a subset of our immune gene set. We saw 
convergence between our geographic regions and those regions of the world with 
endemic hepatitis B infection. This result points to a strong link between infectious 
disease and addiction. We therefore propose that hepatitis B driven infection may be 
a major factor in the changes in allele frequencies in seen in five alleles on 
chromosome 11, of which three are involved with the liver interactome and one is 
involved with schizophrenia phenotypes. These alleles present compelling evidence 
for further selection analyses to identify whether hitchhiking, the rise of alleles in 
proximity to a selected allele, is the mechanism for these variant differences. 
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Appendix C: KEGG Pathway of Systematic Lupus Erythematosus in humans. 
  
 
 
  
120 
 
Appendix D: Final SNP Table- All SNPs generated for the all allelic polymorphisms found in 
the genome. 
dbSNP ID Gene Position 
rs1800708 HFE intron 
rs9366637 HFE Intron  
rs2237231 HIST1H1A downstr. 500B 
rs9393682 HIST1H1C upstr. 2KB 
rs2051542 HIST1H1T missense 
rs3830054 HIST1H2AB upstr. 2KB 
rs6908263 HIST1H2AC intron 
rs7760713 HIST1H2AC intron 
rs9467684 HIST1H2BD intron 
rs4145878 HIST1H2BF upstr.2KB intron 
rs1892252 SLC17A4 intron 
rs3734525 SLC17A4 utr 3’ 
rs3823151 SLC17A4 intron 
rs199738 TRIM38 utr 5’ 
rs6906576 Intergenic genomic 
rs6924948 Intergenic genomic  
rs7740793 Intergenic genomic 
rs9348699 Intergenic genomic 
rs933199 intergenic  Genomic 
rs11819869 AMBRA1 intron 
rs17790342 C11orf49 intron 
rs12417519 C11orf49 intron 
rs752849 C11orf49 intron 
rs901746 DDB2 intron 
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Appendix E: GWAS3D- Identification of the European long distance interactions  
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3. “Genetic Implication of Infectious Diseases in African Populations” ASWAD 
Barbados 2007 
4. “Lessons Learned in International Technical Assistance” National HIV Prevention 
Conference 2001 
5. “Technical Assistance and Capacity Building between US Health Departments 
and Community Based Organizations” HIV/AIDS Prevention Community 
Planning Leadership Conference 2000 
6. “Youth Participation in HIV/AIDS Prevention and Care” United States Conference 
on AIDS 1999 
 
Posters 
1. Jackson, L., Liu, Y., and Tozeren, A. “Whole Genome Analysis of Addiction and 
Their Population Subtypes” Am Soc. Human Genetics International Meetings 
2013 
2. Borgelin, L.* and Hammer, M.F.  “What is structuring STRUCTURE? 
Understanding the underlying implications to a population structure algorithm” 
Society for Molecular Biology and Evolution International Conference 2010 
3. Borgelin, L.*, Keck, M, and Morales, D.A.M. “Using Entropy to Identify 
Functional Motifs on the Y-Chromosome in Humans” National Science 
Foundation IGERT Program Grantees Meeting 2006 
4. Jackson, L., Rastogi, R. and Sakolsky, N. “Technical Assistance and Capacity 
Building between US Health Departments and Community Based Organizations” 
HIV/AIDS Prevention Community Planning Leadership Conference 2001 
 
Academic Service 
Bioinformatics Mentor, Master Charter High School Internship Program                 
Spring2014 
Mentor, Sunnyside High School Students College Application Program 
 2007-2008 
Executive Secretary, University of Arizona Black Graduate Student Association
 2007-2008 
Panel Member, University of Arizona African American Recruitment Weekend 
 2007 
Contributor, Book: Min Første Dansker       Fall 2004 
Steering Committee Member, United States Conference on AIDS   
 1999-2001 
 
Professional Associations 
• Member, American Society for Human Genetics 
127 
 
• Member, Society for Molecular Biology and Evolution 
• Member, Society for Mathematical Biology 
• Past Member, Association for the Study of the Worldwide African Diaspora 
• Past Member, Genetics Society of America 
• Past Member, National Science Teachers Association 
 
Awards, Fellowships and Grants 
• Rice University XSEDE High-throughput Computer Science Fellow 
 2012-14 
• FASEB MARC Travel Award to ASHG 2013     2013 
• Drexel University Dept. of Education GAANN Fellow   
 2012-14 
• University of Arizona Outstanding Student Service Nominee  
 2007-8 
• NSF G-K12 Biology from Molecules to Ecology Fellow   
 2007-8 
• NSF Interdisciplinary Graduate Education and Research Traineeship Grant
 2005-7 
• University of Copenhagen Scholarship Award    
 2004-5 
• Office of Multicultural Student Education Academic Excellence Award  
 1993  
• University of Maryland-Africa in the Americas Seminar Grant Recipient 1994 
 
Laboratory Competencies 
Molecular Biology:   
DNA/RNA: PCR, DNA/RNA purification, cloning, 
Southern/Western/Northern blotting, genomic/cDNA library 
construction and screening, mutagenesis, DNA sequencing, gene and 
promoter analysis and many other common approaches for detection 
and manipulation of nucleic acids. 
Bioinformatics: 
• Gene identification/ annotation tools, gene prediction, motif prediction and 
analysis 
• Competancies in software packages including: Strider, Oligo, Primer3, 
Galaxy, STRUCTURE, ADMIXture, DNAsp, Arlequin, Netlogo, MrBayes.  
   
Computer Skills 
• Microsoft Office suite (such as Microsoft Word, Access, Excel, and Outlook) 
• Macintosh Apple word processing and graphics suite 
• Presentation Software: PowerPoint and Claris Impact 
• Desktop Publishing Software: Adobe PageMaker, Claris Works, Ofoto, Adobe 
Acrobat Writer, and Adobe Photoshop 
• Internet Software: Netscape and Internet Explorer 
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Extended International Travel 
Tanzania, Liberia, Lithuania, Poland, Hungary, Spain, Norway, Sweden, 
Denmark, Guyana, Bahamas, Dominican Republic, Egypt, England, Nigeria, 
Burkina Faso, Ivory Coast, Italy, Czech Republic, Turkey, Barbados,  Mexico 
and France. 
 
Languages 
Professionally Fluent in Danish  Professionally Proficient in French
  Professionally Fluent in American English  Conversational 
Rudimentary Arabic 
 
Programming language competancies: Matlab, PERL, and some familiarity 
with Python/R 
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